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ABSTRACT 
 
 
The Effect of Pet Ownership/Attachment on the Stress Level of Multiple Sclerosis  
 
Patients.  (August 2004) 
 
Ashley Marie Loven, B.S., Texas A&M University 
Chair of Advisory Committee: Dr. Margaret Slater 
 
 
 
Multiple Sclerosis (MS) is the most common demyelinating disease affecting the 
central nervous system.  Over 80% of MS patients are in the relapsing remitting stage.  
Symptoms range from fever, fatigue, emotional distress, tingling, numbness, optic 
neuritis, spasticity, muscle weakness, impaired coordination, to other abnormal 
neurological problems.  Expression of symptoms is known as a relapse or exacerbation.  
The cause of relapses is unknown, but multiple factors seem to play a significant role.  
Possible factors that may influence MS onset and relapse consist of a genetic 
association, viruses, disruption of the blood-brain barrier, and stress.  Stress has shown 
to have negative implications and may stimulate relapses.  Thus, this study examined a 
possible stress intervention that most people already had available to them, companion 
animals.  Companion animals have been shown to lower blood pressure, decrease heart 
rate, provide social support, and reduce stress.  The main hypothesis was to evaluate 
whether or not pet ownership and/or attachment influenced the perceived stress level and 
number of negative life events experienced by MS patients in the relapsing remitting 
stage.  Participants were given a questionnaire that consisted of 7 surveys.  The 
questionnaire accessed quality of life, disease severity, number of negative life events, 
 iv
perceived stress level, level of depression, social support, and pet ownership and 
attachment level.  Our sample population consisted of MS patients seen at the University 
of Texas Southwestern Neurology clinic from February 23rd to May 21st, 2004.  One 
hundred and forty seven relapsing remitting MS patients were included in the study.  
Multiple linear regression was used to compare the relationship of stress and number of 
negative life events to pet ownership and attachment.  Results revealed that pet 
ownership and attachment levels did not affect the stress level and number of negative 
life events of MS patients.  No confounders were identified.  Interaction terms with 
disease severity as the dependent variable, pet ownership and perceived stress level or 
negative life events as the independent variables were not significant.  The type of pet 
owned did not influence the attachment level of the MS patient.  In conclusion, the 
results of this study did not support the hypothesis. 
     
 v
DEDICATION 
 
 
I would like to dedicate this thesis to my family and friends who supported me 
throughout college.  Also, to my Dad (James Loven) and my aunt (Gay Nell Smith) in 
hopes that one day there will be a cure for MS. 
 vi
ACKNOWLEDGEMENTS 
 
 
 I would like to thank my advisor, Dr. Margaret Slater, for her advice and 
revisions of my work.  She provided me with a better understanding of material I had 
learned throughout my master's degree.  I would also like to thank Dr. Jane Welsh and 
Dr. Mary Meagher for their help and dedication to working with me on this thesis.  They 
provided feedback and suggestions that were very helpful. 
 I want to thank the staff of the University of Texas Southwestern Neurology 
Clinic and Dr. Michael Racke for distributing the questionnaires and ensuring they were 
filled out and sent back to me.  In addition, I am very grateful for the MS patients that so 
graciously devoted their time to filling out the questionnaire.        
 Another special group that participated in making sure the surveys were 
understandable and clear was the Brazos Valley MS Society.  They volunteered their 
time and efforts to helping me put the questionnaire together. 
 I want to extend my gratitude to some people that I could not have done this 
without: Linda Campbell and Wes Highfield for their help with the statistical analysis, 
Briget Da Graca for editing the literature, and Dr. Geoff Fosgate, Dr. Bo Norby, and Dr. 
Morgan Scott for their technical assistance.  Also, I would like to thank Gabriela Cantu, 
Norma DeAnda, and Summer Strickland for their help and support. 
    
 
 
    vii
TABLE OF CONTENTS 
 
 
Page 
 
ABSTRACT…………………………………………………………………………     iii 
 
DEDICATION………………………………………………………………………     v 
 
ACKNOWLEDGEMENTS…………………………………………………………     vi 
 
TABLE OF CONTENTS……………………………………………………………    vii 
 
LIST OF FIGURES…………………………………………………………………     ix 
 
LIST OF TABLES………………………………………………………………….     x 
 
INTRODUCTION ………………………………………………………………….     1 
 
  T Cells in Autoimmunity…………………………………………...      2 
  Genetics and MS…………………………………………………....      3      
  Viruses and MS…………………………………………….……….      4 
  Blood-Brain Barrier………………………………………………...      4 
  Stress and MS………………………………………………………      5 
  Human Animal Bond……………………………………………….      7 
 
MATERIALS AND METHODS……………………………………………………    10 
 
Participants...……………………………………………….……….     10 
Questionnaires………………………………………………………     11 
Statistical Analysis………………………………………………….     18 
 
RESULTS………………………………………………………….………………..     22 
 
  Data Collection……………………………………………………...     22 
  Disease Severity Components………………………………………     40 
  Correlations…………………………………………………………     43 
  Interactions………………………………………………………….     48 
  Type of Pet Owned………………………………………………….     49 
  Younger Age Group…………………………………………………    50 
 
 
 
    
    viii
   Page 
 
DISCUSSION AND CONCLUSIONS………….………………………………….     51 
 
Strengths and Limitations..………………………………………….     56 
Recommendations…………………………………………………...     58 
 
REFERENCES………………………………………………………………………     59 
 
APPENDIX.……………………..…………………………………………………...     63 
 
VITA………………………………………………………………………………….    79 
 
                   
 
 
 
 
 
 
 
 
 
  
 
 ix
LIST OF FIGURES 
 
 
FIGURE          Page 
 
1 Histogram of age…………………………………………………..     26 
 
2 Histogram of income………………………………………………     26 
 
3 Histogram of the FAMSQLI score…..……………………………     27 
 
4 Histogram of the disease severity score…………………………...     27 
 
5 Histogram of the LES score………………………………………..    28 
 
6 Histogram of the PSS score………………………………………..     28 
 
7 Histogram of the PHQ score……………………………………….     29 
 
8 Histogram of the SSQ score for number of individuals……………    29 
 
9 Histogram of the SSQ score for satisfaction……………………….    30 
 
10 Histogram of the CABQ score…………………………………….     30 
 
11 Histogram of the CCAQ score…………………………………….     31 
 
     12               Interaction graph of LES score with income and pet 
ownership………………………………………………………….     40 
      
 x 
LIST OF TABLES 
 
 
TABLE          Page  
 
1 Data collected via survey………………………………………….     18 
     
2 Demographic variables of the study population…………………..     23 
 
3 Descriptive statistics for continuous variables……………………     25 
 
4 LES regression coefficients of individual variables………………     32 
 
5 LES regression coefficients of pet ownership and other  
variables in the variable column…………………………………...    33 
 
6 LES regression coefficients of CABQ and other  
variables in the variable column…………………………………..     34 
 
7 LES regression coefficients of CCAQ and other  
variables in the variable column…………………………………..     35 
 
8 PSS regression coefficients of individual variables………..……..     36 
 
9 PSS regression coefficients of pet ownership and other  
variables in the variable column…………………………………..     37 
 
10 PSS regression coefficients of CABQ and other  
variables in the variable column…………………………………..     38 
 
11 PSS regression coefficients of CCAQ and other  
variables in the variable column…………………………………...     39 
 
12 Factor analysis for questions that comprise the disease  
severity score: total variance explained……………………………     41 
 
13 Factor analysis for questions that comprise the disease  
severity score: component matrix………………………………….     42 
 
14 Spearman rank correlation coefficient of dependent  
variables: nonparametric…………………………………………..     43 
 
15 Spearman rank correlation coefficient of independent  
variables……………………………………………………………     44 
 
 
 xi 
TABLE              Page 
 
16 Interaction between PSS score and pet ownership with 
disease severity as dependent variable………………………………     48  
 
17 Interaction between LES score and pet ownership with 
disease severity as dependent variable………………………………     48 
 
18 Significant test for attachment level (defined by the CABQ 
score) of cat owners vs. dog and/or all others……………………….     49 
 
19 Significant test for attachment level (defined by the CCAQ 
score) of cat owners vs. dog and/or all others……………………….     49 
 
     20  LES regression coefficients…………………………………………      50 
 
     21  PSS regression coefficients………………………………………….     50 
 
  
1
 
INTRODUCTION  
 
 
Multiple sclerosis (MS) is a neurodegenerative, autoimmune disease that affects 
the central nervous system, which consists of the brain, spinal cord, and optic nerves.  
According to a revision of the 1990 US Census, an estimate of 250,000 to 350,000 
people in the United States have physician-diagnosed MS (Anderson et al., 1992).  
Epidemiological studies indicate a higher frequency of MS in temperate climates than in 
areas near the equator.  Women have a higher incidence of relapsing-remitting MS 
compared to men, with a female: male ratio of 2:1 (Minagar and Alexander, 2003).   
In multiple sclerosis, the immune system attacks the myelin sheath surrounding 
myelinated nerve fibers (Sherwood, 2001), resulting in scar tissue, which gives the 
disorder the name sclerosis.  Myelin is fatty tissue that surrounds and protects the nerve 
fibers of the CNS and assists in the conduction of electrical impulses.  The ability of 
nerves to conduct electrical impulses is disrupted when the myelin of the nerve fiber is 
destroyed or damaged.  Damaged areas of myelin are referred to as plaques or lesions, 
and are thought to result from an immunological response (Rose, 1974).  The MS lesion 
is characterized by an infiltration of lymphocytes, plasma cells, and macrophages 
contributing to the destruction of the myelin sheath (Janeway et al., 2001a).  The 
destruction and inflammatory damage to the myelin sheath, known as demyelination, 
inhibits action potentials in the underlying axons, and thus produces various symptoms 
of MS (Sherwood, 2001; Van Noort, 1996). 
________ 
This thesis follows the style and format of the Journal of Neuroimmunology. 
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Symptoms of MS vary greatly depending on the extent and location of the myelin 
damage.  Possible symptoms include fever, fatigue, emotional distress, tingling, 
numbness, optic neuritis, spasticity, muscle weakness, impaired coordination, and other 
abnormal neurological problems (Rose, 1974; Sherwood, 2001).  There are 4 clinical 
stages of the disease: relapsing-remitting, secondary progressive, primary progressive, 
and progressive relapsing.  This study only concentrates on the relapsing-remitting stage, 
which represents more than 80% of MS patients (Minagar and Alexander, 2003).  In the 
relapsing-remitting stage, patients experience acute attacks on the myelin, damaging the 
nerve fibers and sometimes the axons themselves, resulting in the expression of the 
symptoms listed above.  An MS “attack” is commonly called a relapse or exacerbation.  
In relapsing-remitting MS, a relapse is followed by remission, which may mean either 
complete or partial recovery. 
T cells in autoimmunity 
 T cell autoimmunity plays a key role in the pathogenesis of MS.  T cells regulate 
immune responses and are responsible for recognizing peptide antigens bound to human 
leukocyte antigen (HLA) class I or class II molecules on the surface of antigen-
presenting cells (Hohlfeld et al., 1995).  T cells possess many different antigen-specific 
receptors that are regulated by somatic gene rearrangement (Janeway et al., 2001b; 
Matis, 1990; Staudt and Lenardo, 1991).  T cell antigen-specific receptor diversity 
allows for T cells to respond to a multitude of antigens.  Antigen presenting cells 
associated with HLA class I process endogenous proteins such as viruses, and HLA class 
II process exogenous proteins (Hohlfeld et al., 1995).  A peptide binding cleft is present 
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on both HLA class I and class II molecules that face the T cell receptor (TCR), with the 
majority of the peptides bound to HLA representing endogenous self peptides (Hohlfeld 
et al., 1995).  The immune system produces autoreactive lymphocytes capable of 
reacting to self-antigen.  The body either destroys the autoreactive lymphocytes in early 
development or accommodates these T cells by inactivating them and inducing a state of 
self tolerance (Hohlfeld et al., 1995).  Self-tolerance allows the immune system to 
respond only to foreign antigen, and not to self antigen (Hohlfeld et al., 1995).  In 
multiple sclerosis, self-tolerance is disrupted by a mechanism not yet determined.  Two 
explanations have been suggested.  The first theory suggests the inactivated T cells that 
are normally exposed to self antigen become activated (Hohlfeld et al., 1995).  The 
second theory proposes the loss of self-tolerance allows expression of autoantigen on 
antigen-presenting cells that normally do not express detectable amounts of HLA class I 
or II molecules, for example most CNS cells (Hohlfeld et al., 1995).  The actual 
pathogenic mechanisms engaged in MS remains controversial. 
Genetics and MS 
Since the etiology of MS is unknown, investigators evaluate factors that may 
influence onset and relapse.  Many factors underlie susceptibility to the disease and 
exacerbations, such as a genetic predisposition, a viral infection, and/or environmental 
exposures.  Genetic predisposition lies within susceptibility mapped by linkage and 
association.  Linkage identifies genes of people with the disease within the same family.  
Association evaluates the genes that differ between those with the disease and those 
without the disease.  In a meta-analysis, the genetic analysis statistically confirmed that 
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the HLA region on chromosome 6p21 supported a genetic linkage to MS (Haines et al., 
2003).  However, genetic association studies report inconclusive conclusions compared 
to each other regarding genetic association (Haines et al., 2003).  Currently, conclusive 
evidence for a specific gene that may cause MS has not yet been identified. 
Viruses and MS 
As the search continues to find the cause of MS, viral infections pose important 
implications to the disease.  Viruses have the capability to activate T cells, causing them 
to express adhesion molecules and thus allowing the T cells to cross the blood-brain 
barrier.  This in turn, causes an immune reaction in the CNS (Van Noort, 1996).  Studies 
show that the human herpes virus 6 (HHV-6) and Epstein-Barr virus (EBV) present 
significant associations with MS (Friedmann et al., 1999; Gilden, 2001; Levin et al., 
2003).  Conventional beliefs associated the canine distemper virus (CDV) and measles 
as possible causative agents for MS (Madden et al., 1981).  Studies found that measles 
antibodies were significantly elevated in MS patients, but this was not true for that of 
CDV (Cook et al., 1978; Madden et al., 1981).  Although associations between viruses 
and MS are significant, a causal link to a specific virus has not been made.   
Blood-Brain Barrier  
The blood-brain barrier (BBB) acts as a selective barrier that limits access of 
blood-borne materials into the CNS.  The BBB consists of zonula occludens between 
endothelial cells of the capillaries, which prevent the passage of inappropriate substances 
into the CNS.  It also involves zonula adherens that hold cerebral endothelial cells of 
capillaries in the CNS tightly together, maintaining the BBB’s restrictive properties.  
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Inflammatory cytokines such as, IFN-γ, TNF-α, and IL-1β, disrupt the blood-brain 
barrier of MS patients when they come in contact with the cerebral endothelial cells and 
disturb the zonula occludens and adherens (Minagar and Alexander, 2003).  It is possible 
the activation of T cells and their interaction with adhesion and migration molecules 
allows them to pass into the CNS.  Alternatively, the endothelial cells lining the BBB 
may be prompted to increase surface expression of adhesion and migration molecules 
and in return attract activated T cells and permit their entry into the CNS (Van Noort, 
1996).  Whatever the mechanism that permits T cells to cross the BBB, the cytokines 
they produced in the CNS influence an acute immune response in the CNS.  
Immunohistochemical evaluation of MS lesions provides evidence of an immune 
reaction occurring in the CNS involving lymphocytes, macrophages, cytokines, and 
adhesion molecules (Gilden, 2001; Van Noort, 1996).  During an MS attack, CNS 
proteins, including myelin basic protein, are attacked and destroyed (Poliak et al., 1997; 
Van Noort, 1996).  Cytokines contribute to the signaling process for T cells to act upon 
antigen/HLA complexes, but T cells also require costimulatory molecules such as CD40 
and CD8 for activation (Van Noort, 1996).  According to Van Noort, costimulatory 
molecules are only present in damaged or stressed sites, which are the only sites where T 
cells may be activated (Van Noort, 1996). 
Stress and MS   
Stress is commonly known to have negative effects on disease processes, 
including MS.  The hypothalamus-pituitary-adrenal axis, which is a feedback 
mechanism for intra-CNS stress responses, is more active in MS patients than normal 
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individuals (Van Noort, 1996).  Mast cell degranulation can also be part of a stress-
induced immune response.  A study using rats found that in rats stressed by 
immobilization, an increase in mast cell degranulation occurs (Esposito et al., 2001).  In 
addition, many mast cells have vasoactive properties and are thought to be capable of 
regulating the permeability of the blood-brain barrier (Theoharides, 1990).  
Degranulation of mast cells in stressed rats was associated with alterations in blood-
brain barrier permeability and breakdown (Esposito et al., 2001).  Change in blood-brain 
barrier permeability and breakdown are seen before new lesions form in MS patients 
(Esposito et al., 2001).  Stress can also induce the production and release of nitric oxide 
from activated macrophages, which activates an adverse immune reaction, such as a MS 
relapse (Esch et al., 2002).  According to Warren, MS patients reported undergoing more 
stress and stressful life events in the 2-year period prior to onset age of MS compared to 
controls (Warren et al., 1982).  It has not been proven that stress causes MS, but it may 
stimulate exacerbations.  In MS patients, it has been found that stress precipitates 
exacerbations within an average of 14 days (Ackerman et al., 2002).  According to 
Ackerman, six weeks prior to an exacerbation, 85% of the MS patients in his study 
experienced one or more stressful life event (Ackerman et al., 2002).  Since stress has 
such significant negative implications in MS patients, limiting the effects of stressful life 
events and stress prevention may prove an important early intervention in treating and 
living with MS. 
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Human Animal Bond 
The human animal bond, also referred to as pet attachment, and its influences on 
human stress levels, is a field that has drawn considerable interest.  Studies demonstrate 
that having a pet tends to lower blood pressure, provide social support, and reduce stress 
(Davis, 1991; Patronek and Glickman, 1993).  A study evaluating heart rate and blood 
pressure in children while reading and resting revealed that the children’s heart rate and 
blood pressure was lowered when an unfamiliar dog entered the room than when the dog 
was not present in the room (Friedmann et al., 1983).  The one-year survival rate after 
discharge from a coronary care unit was significantly higher for those patients who 
owned pets (Friedmann et al., 1980).  In a prospective study of 8000 people enrolled in a 
preventive health program in Australia, women over the age of 40 and men of all ages 
who owned a pet had lower blood pressure than those who did not own a pet (Rowan, 
1991; Serpell, 1990).   
Pet ownership not only has health benefits, but also provides social support for 
individuals.  Humans need social support, and if lacking, individuals may suffer an 
increase in stress levels and experience feelings of depression (Friedmann et al., 1980; 
Katcher, 1981).  Companion animals can provide social support and behavior benefits 
that lower the stress levels of individuals.  Cats have been found to be a complementary 
part of patients’ social network and emotional support (Stammbach and Turner, 1999).  
Twenty-two residents with Alzheimer’s disease in a long-term care facility showed an 
increase in smiles, tactile contact, looks, and physical warmth in the presence of a dog 
(Batson et al., 1995).  Furthermore, elderly people reported a decrease in depressive 
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symptoms when they formed emotional attachments to companion animals (Garrity et 
al., 1989). 
Animal interactions, such as pet ownership and attachment, can help relieve 
stress and decrease the feelings of anxiety, depression, and emotional distress.  People 
with a low support level from family and friends exhibit stronger pet attachments and 
report fewer illnesses than those who have a higher human support level (Garrity et al., 
1989).  In addition, a lower level of depression is associated with a higher level of pet 
attachment when the level of confidant support is low (Garrity et al., 1989).   
The number and severity of disease-related symptoms, social and family 
environments, the availability and utilization of support systems, and the patients’ 
personal assessment of the disease relate to the amount of stress MS individuals 
encounter (Jean et al., 1997).  Physical and mental stress can increase a person’s heart 
rate, blood pressure, and anxiety levels.  In a study of 92 college students, it was found 
that the presence of an unfamiliar dog had a relaxing, anti-anxiety effect on the students, 
reducing cardiovascular dysfunction (Wilson, 1991).  According to Allen, hypertensive 
patients given Lisinopril, an ACE inhibitor, in accompany with a pet ownership 
assignment had significantly lower responses to mental stress than those who were only 
given Lisinopril (Allen et al., 2001).  While performing stressful tasks in the presence of 
a pet dog, adult women showed less physiological reactivity (autonomic response), than 
when performing the same tasks with a female human friend present (Allen et al., 1991).  
If pets are able to lower patients’ responses to stress, they may not only protect the 
owner from the risks and consequences of coronary heart disease, but may also reduce 
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the severity of MS.  MS patients must consider lifestyle changes that reduce 
psychosocial and psychological stressors and so help decrease severity of disease-related 
symptoms (Jean et al., 1997).   
No studies have evaluated the pet attachment levels of MS patients in relation to 
their stress levels.  Interactions with animals may lower the everyday stress MS patients 
experience and so decrease the severity of MS symptoms.  This research project aimed 
to evaluate the stress levels of MS patients and whether the presence of a pet, as well as 
the extent of patient/pet attachment, can affect the stress level or response to stress of 
MS patients.  The objectives determined were: (1) the current assessment of quality of 
life and disease severity of the MS patient; (2) the stress incurred from life events within 
the last 12 months; (3) the patients’ perceived stress level in the last month, including 
their mood in the last 2 weeks; (4) the patients’ social support network; and (5) the 
patients’ attachment level, if any, to the pets currently owned or interacted with during 
the last 12 months.  Responses to questionnaires were used to quantify MS patients’ 
stress levels and pet attachment levels, and to compare whether attachment to a pet 
makes a difference in the perceived stress level of the MS patient.    
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MATERIALS AND METHODS 
 
 
Participants 
 
Multiple Sclerosis patients from the University of Texas Southwestern 
Neurology (UTSN) clinic were recruited for participation in this study.  The Texas 
A&M University and University of Texas Southwestern Medical Center Institutional 
Review Board approved this study.  This study recruited only people who voluntarily 
consented to participation.  Recruitment of participants involved giving MS patients 18 
years of age and older an introductory letter along with the study survey, when they 
appeared for their normally scheduled appointment at the UTSN clinic.  The 
introductory letter consisted of an explanation of the study, the approximate time it 
would take the participant to complete the survey, the method of return of the survey, 
emphasis on anonymity of the information the participants provided, and reassurance 
that the study was strictly voluntary.  Individual responses were anonymous and neither 
the investigators nor the physicians knew peoples’ personal responses.  Compensation 
was not provided for completing the survey.  To obtain an adequate number of 300-400 
respondents, approximately 500 surveys and introductory letters were printed and given 
to the UTSN clinic to distribute to MS patients.  This study only focused on MS patients 
in the relapsing-remitting stage of MS, including male and female, adults 18 years of age 
or older, and of diverse ethnicities.  The UTSN clinic provides care to those who are not 
able to pay, on Medicare and/or Medicaid, and those with private insurance. Participants 
completed the survey in the clinic while they waited for their appointment.  If a person 
chose not to participate in the study, a request to check the box on the first page of the 
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survey stating, “I chose not to participate” existed.  Once they had completed the survey, 
the participant presented the first page of the survey to their physician for him/her to 
verify their current stage of disease.  Participants dropped their completed survey in a 
box, which were mailed to the investigators for data analysis.  The surveys were kept in 
a secure locked office in the Veterinary Medical Science Building at Texas A&M 
University.  Once the surveys were returned, they were assigned a unique identification 
number to provide a reference as to which data belonged to which survey.  The data was 
entered into a customized MS Access database.  Random sampling of 10% of the 
surveys was used to check for accuracy of data entry.  Data from the surveys was also 
checked by comparing the maximum and minimum values of each response 
questionnaire to the actual range of values each questionnaire exhibited.  The data was 
uploaded into the statistical software package SPSS v.11.0.     
Questionnaires   
A combination of six validated questionnaires and one widely used questionnaire 
were included to quantify the variables.  The Functional Assessment of Multiple 
Sclerosis Quality of Life Instrument (FAMSQL) was used to evaluate the quality of life 
and to judge disease severity, which was a potential confounding factor (Cella et al., 
1996).  The Life Events Scale (LES) and Perceived Stress Survey (PSS) assessed the 
number of negative life events that had occurred in the participants' life in the past 12 
months and the stress level of the participants, respectively (Cohen et al., 1991); (Cohen 
and Williamson, 1988).  A section of the Patient Health Questionnaire (PHQ) was used 
to determine depression levels (Spitzer et al., 1994).  The Social Support Questionnaire 
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(SSQ) was used to assess patients’ social support network (Sarason et al., 1987).  The 
Companion Animal Bonding Questionnaire (CABQ) and Comfort from Companion 
Animals Questionnaire (CCAQ) evaluated the patients’ attachment level to their pet(s) 
(Poresky et al., 1987); (Zasloff, 1996).   
 A brief questionnaire inquiring about demographic variables such as age, sex, 
ethnicity, employment, income, and education were used to acquire general information 
regarding the participants.  The answers to this demographic questionnaire were 
categorical variables. 
The FAMSQLI is divided into six subscales: Mobility, Symptoms, Emotional 
Well-Being (depression), General Contentment, Thinking and Fatigue, and 
Family/Social Well-Being.  It was used to judge potential confounders such as quality of 
life and disease severity a patient exhibited.  “Quality of life is a term used in 
contemporary social science to refer to a person’s subjective sense of well-being or 
satisfaction with important areas of life” (Cella et al., 1996).  The FAMSQLI assessed 
patient functioning using a five-point (0-4) Likert-type response scale consisting of items 
that have general relevance for chronic illness and specific relevance to the symptoms 
and problems associated with MS (Cella et al., 1996).  The response ratings range from 0 
(not experiencing what the question is asking at all) to 4 (experiencing what the question 
is asking very much).  Reverse coding was used for negative events.  A higher score 
indicates a higher quality of life compared to a lower score.  To explore meaningful 
quantitative descriptions about participants, the questions in the FAMSQLI are designed 
to assess the same trait in each subscale and measure the trait on a linear scale so that the 
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responses may be added and quantified (Cella et al., 1996).  FAMSQLI consists of 59 
items.  A total score can range from the lowest quality of life and severe disability at 0 to 
the highest quality of life and no disability at 236.  The questionnaire is self-explanatory 
and allows for the patient to answer quickly and accurately.  The survey’s validation 
consisted of multiple patient groups and compared the means between them.  The results 
revealed consistent and complementary evidence for internal consistency, test-retest 
reliability, content validity, concurrent validity, and construct validity (Cella et al., 
1996).  Cronbach’s alpha ranged from 0.82 to 0.96 and indicated homogeneity of the 
questions, ensuring internal consistency (Cella et al., 1996).  The test-retest reliability 
coefficients ranged from 0.85 to 0.91 to express reliability (Cella et al., 1996).  The 
FAMSQLI provides a way for surveying MS patients and evaluating the symptoms, 
problems, and psychosocial issues they possess to provide a measure of disease severity 
and quality of life with high levels of validity and reliability.   
Specific questions that related to the patients functionality were selected and 
resulted in the inclusion of 36 questions.  These 36 questions produced the disease 
severity score that was obtained as a subset of the FAMSQLI.  A factor analysis was run 
on the questions to evaluate their ability to describe the questions’ relationships with 
each other.  These questions combined together were tested for reliability and resulted in 
a Cronbach’s alpha equal to 0.94. 
 The LES evaluates life events that can be viewed as positive or negative.  It is 
composed of 24 questions.  Eleven questions contain yes/no responses and a six-point 
Likert rating scale to assess if the event had a positive or negative impact on the 
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participant.  The ratings range from ‘very good’ to ‘very bad’.  If the participant 
considers the event to be ‘bad’ at all it is considered a negative event.  The remaining 13 
questions ask about the occurrence of a negative event and have only a yes/no response 
available.  A total score represents the number of negative life events that occurred in the 
participant’s life in the past 12 months and can range from 0 (no negative life events) to 
24 (negative life events).  The questions in the LES were compiled by Cohen (Cohen et 
al., 1991) and originated from the List of Recent Experiences by Henderson (Henderson 
et al., 1981).  This questionnaire was chosen based on its ability to question relevant 
negative life events that occur in large numbers of populations studied (Cohen et al., 
1991).             
 The PSS10 was the third component of the total survey.  The PSS10 consists of 
ten items presented in a five-point Likert scale and measures the degree of stress that one 
experiences in life situations, viewed as stressful by the patient (Cohen and Williamson, 
1988).  The responses rate how often the participant felt or thought a certain way and 
range from 0 (never) to 4 (very often).  A total score can range from 0 to 40 with a 
higher score indicating a higher stress level versus a lower score.  The items evaluate 
how unpredictable, uncontrollable, and overloaded the respondents perceive their lives 
(Cohen and Williamson, 1988).  The PSS10 was chosen because the items are easy to 
understand and it can be self administered quickly. The PSS10 is diverse in that it 
contains items that express negative and positive wording, which can easily be scored.  It 
demonstrated a high internal reliability alpha coefficient score of 0.78 as well as a high 
degree of validity (Cohen et al., 1983).  
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 The section of the PHQ utilized by this study assessed a measure of depression 
severity (Spitzer et al., 1999).  The PHQ was originally derived from the PRIME-MD, 
which was longer and required physician assistance.  The PHQ represents a revised and 
shortened version of the PRIME-MD that can be self-administered in a timely manner.  
The PHQ section that inquires about depression consists of 9 questions in a 4 point-
Likert scale, asking for a response rating of 0 (not experiencing the question being asked 
at all) to 3 (experiencing the question being asked nearly every day).  A total score can 
range from 0 to 27 with a higher score indicating a more severe level of depression.  
This questionnaire provides a mean to quantify responses and a way to categorize 
responses.  A person filling out the depression section of the PHQ can be categorized by 
the DSM-IV as either “major depressive” or “other depressive”.  Also, those not 
considered depressive exist.  If a person answers question 1 or 2 with “more than half the 
days” or “nearly everyday” and five or more questions experiencing the question at least 
“more than half the days”, they are grouped into the category as a major depressive.  If a 
person answers question 1 or 2 with “more than half the days” or “nearly everyday” and 
two, three, or four more questions with at least “more than half the days”, they are 
grouped into the category as other depressive.  Question 9 will be counted for both 
“major depressive” and “other depressive” if the respondents experience it at all.  The 
depressive section of the PHQ demonstrated a sensitivity of 73% and specificity of 94% 
(Spitzer et al., 1999).  Compared to a mental health professional interview the PHQ 
depressive section experienced a correlation coefficient of 0.84 indicating criterion 
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validity (Spitzer et al., 1999).  The criterion validity measures the ability of the PHQ to 
expresses the actual level of depression.  
 The Social Support Questionnaire used in this study was the SSQ6.  The SSQ6 is 
a short form of the SSQ consisting of 6 questions, shortened from the original SSQ that 
contains 27 questions (Sarason et al., 1987).  Each question has two parts, with the first 
part of the question assessing the number of individuals that the person feels they have 
available to them for support.  The second part uses a 6 point-Likert scale to rate the 
person’s satisfaction with their perceived social support.  The response choices range 
from 0 (very dissatisfied) to 5 (very satisfied) expressing a potential range of total scores 
of 0 to 30.  A higher score indicates a higher degree of satisfaction with the person’s 
perceived social support.  This questionnaire is easily self-administered and can be 
completed quickly.  Its internal reliability ranged from 0.90 to 0.93 for both parts of the 
question (Sarason et al., 1987).  The correlation of the SSQ6 with the Social Network 
List resulted in 0.39 compared to the original SSQ of 0.43 (Sarason et al., 1987).  The 
original SSQ and the SSQ6 were highly correlated with each other, and the SSQ6 
provided a good measure of perceived social support comparable to that of the SSQ.   
 The CABQ provides a direct measure of companion animal bonding which 
stresses the strength of the human-animal bond versus just pet ownership (Poresky et al., 
1987).  Two versions of the CABQ exist: the contemporary scale and the childhood 
scale.  This study used the contemporary scale, which assesses the human animal bond 
in the present tense in contrast to the childhood scale that is written in the past tense.  
The questionnaire can be self-administered and is easy to read and understand.  The 
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CABQ represents animals of all kinds that can be used for companionship, not just dogs.  
The CABQ consists of eight questions and is based on a five-point Likert scale with 
responses of each item ranging from 1 to 5, with a 5 indicating a high level of 
attachment.  A total score can range from 8 to 40 with a higher score resulting in a 
higher level of attachment.  The scale exhibited a high internal reliability expressing a 
Cronbach alpha of 0.82 and showed significant correlation indicating construct validity 
between scores on the Pet Attitude Scale and the Childhood Bonding Scale of a 0.39 and 
0.40, respectively (Poresky et al., 1987).  Construct validity represents how well the 
question that is being asked actually measures the characteristic it proposes to measure. 
 The CCAS measures the level of emotional attachment and perceived comfort 
received from a pet.  It is relatively short and easily understood.  The construct validity 
of the CCAS correlated with the Lexington Attachment to Pets Scale (LAPS) with a 
coefficient of -0.68 (p<0.05) (Zasloff, 1996).  The scales are inversely related.  The 
Cronbach alpha from a pilot reliability test resulted in a value of 0.85 (p<0.01) (Zasloff, 
1996).  A four-point Likert scale measures responses from 1 (strongly disagree) to 4 
(strongly agree), and a higher score results in greater perceived comfort and attachment 
from the pet.  A total score can range from the lowest attachment of 11 to the highest 
level of attachment at 44.  
 Table 1 identifies the response categories for the different demographic variables. 
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Table 1 
Data collected via survey       
Variables Response Categories 
Demographics  
     Age range 5 year intervals 
     Sex male, female 
     Ethnicity  
     Employed yes/no 
     Work outside home yes/no, job title 
     Household income range $15,000/year intervals 
     Education  
     Seen a psychologist/counselor yes/no 
  
FAMSQLI rating scale 0 to 4 
  
LES yes/no, rating scale 1 to 6 
  
PSS rating scale 0 to 4 
  
PHQ rating scale 0 to 4 
  
SSQ list individual's initials, rating scale 0 to 5 
  
CABQ rating scale 1 to 5 
     Presently own pet yes/no 
     Past 12 months own pet yes/no 
     Type of pet dog, cat, horse, rabbit, rodent, reptile, other  
  
CCAQ Rating scale 1 to 4 
 
 
 
Statistical Analysis    
Statistical package SPSS for Windows v. 11.0 was used to analyze the data.  For 
categorical variables (age, sex, ethnicity, employment status, work outside of home, 
household income range, education, whether or not the patient has seen a counselor 
before, and pet ownership) percentages for each category were calculated.  The median 
and range was calculated for the ordinal variables.  The mean, median, range, and 
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standard deviation were calculated for the continuous variables (quality of life score, 
disease severity score, life events score, perceived stress score, depression score, social 
support by number of individuals and satisfaction with support, and pet attachment 
levels).  Histograms were used for evaluation of normality for each continuous and 
ordinal variable.  
The scores from the LES or the PSS10 were used to compute values that 
represent the number of negative life events experienced within the last 12 months and 
the perceived stress level, respectively, as the dependent variables.  Pet ownership and 
attachment level was defined by yes/no variables and the CABQ and CCAQ scores 
represent the independent variables.  Multiple linear regression models using the LES 
and PSS10 as the dependent variables were fit separately.  Possible confounders and/or 
effect modifiers consisted of age, sex, ethnicity, employment, income, education, quality 
of life, disease severity, depression, and social network (human support).  The possible 
confounding variables were evaluated by comparing the change in the regression 
coefficients of the pet variables as they were assessed individually to when they were 
assessed with the other independent variables.    
The general linear model as first-order terms present as: 
Y= βo + β1X 1 + β2X 2 + …..+ βkX k + ε assuming that the effects of the independent 
variables are additive.  Second and third order modeling could be used if needed for 
good model fit.  An F-test and the p-value for each coefficient were used to evaluate the 
significance of the variables in relation to the outcome variable.  The independent 
variables were inserted into the model individually to assess changes in the regression 
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coefficients and changes in significance.  Selection for interactions between independent 
variables was based on biological plausibility and significance of the independent 
variable. 
The four basic assumptions of multiple linear regression were applied and tested.  
Assuming that (1) the errors had equal variances (homoscedasticity), (2) the residuals 
(errors) were normally and independently distributed, (3) the model use correct (linear), 
and (4) that the values of the dependent variables were statistically independent of one 
another (independence) gave rise to the use of valid regression analyses.  To test the 
homoscedasticity, a plot of the standardized residuals against the predicted values was 
conducted.  A scatter of points resembling a horizontal band indicated constant variance.  
A normal probability plot of the residuals (errors) examined normality of the residuals.  
Normal distribution of the residuals resulted in the probability plot exhibiting a straight 
line at 45° to the horizontal.  To test if the models were linear, a plot of the residuals 
against each of the continuous predictor variables or transformations of the Y-variable 
was performed.  Independence of the dependent variables was assumed by the nature of 
the survey resulting from each observation originating from different individuals. 
Correlation coefficients describing how LES and PSS relate to each other were 
determined using nonparametric correlations.  Since the data was not normally 
distributed Spearman’s rank correlation was used to compare the correlation amongst the 
variables.     
An interaction term in the model with pet ownership and perceived stress level as 
the independent variables evaluated disease severity as the dependent variable.  Also, an 
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interaction term evaluating disease severity as the dependent variable, with pet 
ownership and the number of negative life events as the independent variable, was 
calculated.   
A Mann-Whitney test was performed to establish if there was a significant 
difference in attachment levels according to the type of pet that was owned.  Few people 
owned a pet other than a dog or cat.  Those that did own a pet other than a dog or cat 
also owned a dog.  The data were divided and sorted by dog owners, and/or cat owners, 
and all other pets.  The same dummy variable was given to a dog, a dog and cat, and a 
dog and other pet owner.  The people that owned only cats were given the opposite 
dummy variable of the dog, dog and cat, and dog and other pet owner.   
Regression analysis was run on a subset of the data including the younger 
patients 18-43 years of age to assess if pet ownership and attachment had a significant 
effect on their LES and PSS scores.       
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RESULTS 
 
 
Data Collection 
Data collection started February 23rd of 2004 and proceeded until May 21st 2004.  
A total of 204 surveys were distributed amongst patients at the UTSN clinic.  Included in 
the study were 147 participants in the relapsing-remitting stage of MS.  Of the MS 
patients that completed the survey, 122 patients currently owned a pet or had owned a 
pet within the last 12 months and 25 patients did not currently or within the last 12 
months own a pet.  Participants that completed the survey and were excluded from the 
study were 2 benign MS patients, 39 secondary progressive MS patients, 6 primary 
progressive MS patients, 4 other CNS disease patients, 2 that chose not to participate, 
and 3 whom did not complete the full survey.  The 3 that did not complete the full 
survey randomly skipped pages and did not miss the same sections as each other. 
Demographics of the study population were collected.  Ethnicity was defined as 
Caucasian or other.  African American, Hispanic, Asian, or other was grouped together 
to form one “other” variable due to few responses in each category.  Only one 
respondent indicated that they finished 12th grade but did not indicate if he/she graduated 
high school or not.  See table 2 for numbers and percents of the demographic variables 
pertaining to the study population.   
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Table 2 
Demographic variables of the study population 
Demographic Variables Pet Owners Non-Pet Owners P-value 
 N=122 N=25  
Age Range   0.9 
     18-23 4 (3.3%) 2 (8.0%)  
     24-28 7 (5.7%) 1 (4.0%)  
     29-33 13 (10.7%) 3 (12.0%)  
     34-38 20 (16.4%) 6 (24.0%)  
     39-43 20 (16.4%) 3 (12.0%)  
     44-48 25 (20.5%) 3 (12.0%)  
     49-53 11 (9.0%) 3 (12.0%)  
     54-58 15 (12.3%) 3 (12.0%)  
     59-63 6 (4.9%) 1 (4.0%)  
     64-68 1 (0.8%) 0 (0.0%)  
     Median 39-43 39-43  
     Range (18-23)-(64-68) (18-23)-(59-63)  
    
Sex   0.5 
     Male 16 (13.1%) 2 (8.0%)   
     Female 106 (86.9%) 23 (92.0%)  
    
Ethnicity    
     Caucasian 116(95.1%) 19(76.0%)  
     African American 0(0.0%) 5(20.0%)  
     Hispanic 4(3.25%) 0(0.0%)  
     Asian 0(0.0%) 0(0.0%)  
     Other 2(1.64%) 1(4.0%)  
    
Ethnicity (Collapsed)   0.01 
     Caucasian 116 (95.1%) 19 (76.0%)  
     Other 6 (4.9%) 6 (24%)  
    
Employed   0.8 
     Yes 79 (64.8%) 15 (60.0%)  
     No 43 (35.2%) 10 (40.0%)  
    
Work Outside Home   0.1 
     Yes 42 (34.4%) 13 (52.0%)  
     No 80 (65.6%) 12 (48.0%)  
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Table 2 Continued 
Demographic Variables Pet Owners Non-Pet Owners P-value 
Household Income Range   0.7 
     0-15,000 8(6.6%) 2(8.0%)  
     15,001-30,000 8(6.6%) 4(16.0%)  
     30,001-45,000 17(13.9%) 2(8.0%)  
     45,001-60,000 14(11.5%) 3(12.0%)  
     60,001-75,000 10(8.2%) 1(4.0%)  
     75,001-90,000 13(10.7%) 5(20.0%)  
     90,001-105,000 15(12.3%) 2(8.0%)  
     105,000+ 37(30.3%) 6(24.0%)  
     Median 75,001-90,000 75,001-90,000  
     Range (0-15,000)-(105,000+) (0-15,000)-(105,000+)  
    
Education   0.3 
     Finished 12th grade 1(0.8%) 0(0.0%)  
     Graduated High School 15(12.3%) 2(8%)  
     GED 0(0.0%) 1(4.0%)  
     Some College 40(32.8%) 9(36.0%)  
     Bachelor's Degree 43(35.2%) 11(44.0%)  
     Some Graduate School 4(3.3%) 0(0.0%)  
     Graduate Degree 19(15.6%) 2(8.0%)  
    
Seen Counselor  0.5 
     Yes 67 (54.9%) 16 (64.0%)  
     No 55 (45.1%) 9 (36.0%)  
    
Total 122 (83%) 25 (17%)  
a  Ethnicity defined as Caucasian or other. 
 
Descriptive statistics of the continuous variables were also calculated.  The 
number of patients that fell into the major depressive and other depressive categories 
was so small they were not taken into account as separate variables in the analyses.  The 
PHQ was missing from the first 50 questionnaires because of a printing error when the 
surveys were made.  The CABQ and CCAQ only included participants that own pets.  
One participant did not fill out the CCAQ, so N = 121 instead of 122.  See table 3. 
  
25
 
Table 3 
Descriptive statistics for continuous variables 
Continuous Variable Mean Median Range 
Std. 
Dev. 
FAMSQLI 164 176 (44-231) 42.4 
Disease Severity 98 103 (19-146) 27.8 
LES 3.5 3 (0-12) 2.6
PSS 18 17 (1-36) 8.0
PHQ 7 5 (0-26) 6.2
     MDa 19 19 (16-21) 1.9
     ODb 12 12 (11-13) 0.8
SSQ # individuals 21 17 (0-54) 12.0 
SSQ Satisfaction Score 24 26 (0-30) 7.6
CABQ 31 32 (13-40) 5.9
CCAQ 37 39 (14-44) 7.1
MDa (score for major depressive) N=6 (4.1%)    
ODb (score for other depressive) N=7 (4.8%)    
 
 
Histograms were constructed for the independent ordinal variables and the 
continuous variables, as well as the dependent variables to assess normality.  See Figures 
1-11.  Age was categorized by five-year intervals starting with 1 representing 18-23 
years to 10 signifying 64-68 years. See Figure 1.  Income was also categorized into 
15,000 dollar increments.  One represented 0-15,000, 2 represented 15,001-30,000 and 
so on to 8 representing 105,000+.  See Figure 2. 
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Fig. 1.  Histogram of age 
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Fig. 2.  Histogram of income 
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Fig. 3.  Histogram of the FAMSQLI score 
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Fig. 4.  Histogram of the disease severity score 
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Fig. 5.  Histogram of the LES score 
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Fig. 6.  Histogram of the PSS score 
  
29
 
PHQ_SCOR
25.0
22.5
20.0
17.5
15.0
12.5
10.0
7.5
5.0
2.5
0.0
Histogram
Fr
eq
ue
nc
y
30
20
10
0
Std. Dev = 6.17  
Mean = 6.8
N = 97.00
 
Fig. 7.  Histogram of the PHQ score 
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Fig. 8.  Histogram of the SSQ score for number of individuals 
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Fig. 9.  Histogram of the SSQ score for satisfaction  
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Fig. 10.  Histogram of the CABQ score 
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Fig. 11.  Histogram of the CCAQ score 
 
 
The LES and PSS dependent variables were fit separately with pet ownership 
status and the CABQ and CCAQ as independent variables.  The variables were 
examined separately and in conjunction with each remaining independent variable to 
evaluate confounding, interaction, and significance.  P-values of 0.0 in the tables 
represents less than 0.001.  If either independent variable was significant, the interaction 
term was examined for all models with more than one independent variable.  All models 
fit the assumption for linear regression.  See tables 4 through 11.     
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Table 4   
LES regression coefficients of individual variables 
Variables 
Regression 
Coefficient of 
Individual 
Variables P-value R2  
Age -0.003 1.0 0.00 
Sex -0.329 0.6 0.00 
Ethnicity 
(Caucasian)a -0.593 0.4 0.00 
Employed -0.261 0.6 0.00 
Work Outside 
Home -0.275 0.5 0.00 
Income -0.301 0.0b 0.08 
Education -0.058 0.7 0.00 
FAMSQLI -0.017 0.0b 0.08 
Disease 
Severity -0.024 0.001b 0.07 
PHQ 
(depression 
level) 0.114 0.01b 0.07 
Social Support 
Network (# of 
Individuals) -0.002 0.9 0.00 
Social Support 
Network 
(Satisfaction) -0.063 0.02b 0.04 
Pet Ownership 0.067 0.9 0.00 
CABQ 0.021 0.6 0.00 
CCAQ 0.043 0.2 0.02 
a  Not enough other ethnicities to evaluate separately 
b  Significant p<0.05 
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Table 5     
LES regression coefficients of pet ownership and other  
variables in the variable column 
 Regression Coefficients (p-value)  
Variables Pet Ownership Other Variables R2 
Age 0.069 (0.9) -0.004 (1.0) 0.00 
Sex 0.084 (0.9) -0.335 (0.6) 0.00 
Ethnicity 
(Caucasian)a 0.194 (0.7) -0.662 (0.4) 0.01 
Employed 0.080 (0.9) -0.263 (0.6) 0.00 
Work 
Outside 
Home 0.106 (0.9) -0.284 (0.5) 0.00 
Income 0.189 (0.7) -0.303 (0.001) 0.08 
Education 0.128 (0.8) -0.060 (0.7) 0.00 
FAMSQLI -0.055 (0.9) -0.018 (0.0) 0.08 
Disease 
Severity -0.032 (1.0) -0.024 (0.0) 0.07 
PHQ 
(depression 
level) -0.157 (0.8) 0.114 (0.0) 0.07 
Social 
Support 
Network (# of 
Individuals) 0.069 (0.9) -0.002 (0.9) 0.00 
Social 
Support 
Network 
(Satisfaction) 0.195 (0.7) -0.064 (0.0) 0.04 
a  Not enough other ethnicities to evaluate separately 
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Table 6     
LES regression coefficients of CABQ and other  
variables in the variable column 
 Regression Coefficients (p-value)  
Variables C.A.B.Q. Other Variables R2 
Age 0.023 (0.6) -0.044 (0.7) 0.00 
Sex 0.019 (0.6) -0.183 (0.8) 0.00 
Ethnicity 
(Caucasian) 0.021(0.6) -0.738 (0.5) 0.01 
Employed 0.018 (0.7)  -0.403 (0.4) 0.01 
Work 
Outside 
Home 0.018 (0.6) -0.430 (0.4) 0.01 
Income 0.028 (0.5) -0.259 (0.01) 0.06 
Education 0.027(0.5) -0.024 (0.9) 0.00 
FAMSQLI 0.023 (0.5) -0.016 (0.002) 0.08 
Disease 
Severity 0.023 (0.5) -0.022 (0.01) 0.06 
PHQ 
(depression 
level) 0.007 (0.9) -0.106 (0.04) 0.06 
Social 
Support 
Network (# of 
Individuals) 0.025 (0.5) -0.014 (0.5) 0.01 
Social 
Support 
Network 
(Satisfaction) 0.040 (0.3) -0.103 (0.002) 0.08 
a  Not enough other ethnicities to evaluate separately 
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Table 7 
LES regression coefficients of CCAQ and other  
variables in the variable column 
 Regression Coefficients (p-value)  
Variables C.C.A.Q. Other Variables R2 
Age 0.045 (0.1) -0.065 (0.6) 0.02 
Sex 0.042 (0.2) -0.076 (0.9) 0.02 
Ethnicity 
(Caucasian)a 0.043 (0.2) -0.739 (0.5) 0.02 
Employed 0.041 (0.2) -0.326 (0.5) 0.02 
Work 
Outside 
Home 0.043 (0.2) -0.344 (0.5)  0.02 
Income 0.050 (0.1) -0.278 (0.004) 0.08 
Education 0.046 (0.1) 0.007 (1.0) 0.02 
FAMSQLI 0.046 (0.1) -0.016 (0.002) 0.09 
Disease 
Severity 0.044(0.1) -0.022 (0.01) 0.08 
PHQ 
(depression 
level) 0.017(0.7) 0.106 (0.04) 0.06 
Social 
Support 
Network (# of 
Individuals) 0.048 (0.1) -0.018 (0.3) 0.02 
Social 
Support 
Network 
(Satisfaction) 0.060 (0.0) -0.108 (0.001) 0.10 
a  Not enough other ethnicities to evaluate separately 
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Table 8 
PSS regression coefficients of individual variables 
Variables 
Regression 
Coefficient of 
Individual 
Variables P-value R2  
Age -0.212 0.5 0.00 
Sex -2.659 0.2 0.01 
Ethnicity 
(Caucasian)a 1.996 0.4 0.01 
Employed -2.970 0.03b 0.03 
Work Outside 
Home -3.132 0.02b 0.04 
Income -0.787 0.004b 0.06 
Education -1.151 0.04b 0.03 
FAMSQLI -0.133 0.0b 0.50 
Disease 
Severity -0.186 0.0b 0.42 
PHQ 
(depression 
level) 0.752 0.0b 0.33 
Social Support 
Network (# of 
Individuals) -0.170 0.002b 0.07 
Social Support 
Network 
(Satisfaction) -0.410 0.0b 0.16 
Pet Ownership 0.129 0.9 0.00 
CABQ 0.118 0.3 0.01 
CCAQ 0.029 0.8 0.00 
a  Not enough other ethnicities to evaluate separately 
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Table 9 
PSS regression coefficients of pet ownership and other  
variables in the variable column 
 Regression Coefficients (p-value)  
Variables Pet Ownership Other Variables R2 
Age 0.204 (1.0) -0.214 (0.5) 0.003
Sex 0.265 (0.9) -2.677 (0.2) 0.012
Ethnicity 
(Caucasian)a -0.271 (0.9) 2.094 (0.4) 0.005
Employed 0.270 (0.9) -2.978 (0.03) 0.032
Work 
Outside 
Home 0.560 (0.7) -3.178 (0.02) 0.037
Income 0.447 (0.8) -0.792 (0.004) 0.056
Education 0.384 (0.8) -1.158 (0.04) 0.031
FAMSQLI -0.797 (0.5) -0.133 (0.0) 0.499
Disease 
Severity -0.636 (0.6) -0.186 (0.0) 0.421
PHQ 
(depression 
level) -0.678 (0.7) 0.751 (0.0) 0.333
Social 
Support 
Network (# of 
Individuals) 0.244 (0.9) -0.170 (0.002) 0.066
Social 
Support 
Network 
(Satisfaction) 0.953 (0.6) -0.415 (0.0) 0.157
a  Not enough other ethnicities to evaluate separately 
 
  
38
 
Table 10 
PSS regression coefficients of CABQ and other  
variables in the variable column 
 Regression Coefficients (p-value)  
Variables C.A.B.Q. Other Variables R2 
Age 0.126 (0.3) -0.281 (0.4) 0.01 
Sex 0.086 (0.5) -2.795 (0.2)  0.02 
Ethnicity 
(Caucasian)a 0.118 (0.3) 2.639 (0.4) 0.01 
Employed 0.089 (0.50 -3.083 (0.05) 0.02 
Work 
Outside 
Home 0.098 (0.4) -2.914 (0.06) 0.04 
Income 0.139 (0.3) -0.757 (0.015) 0.06 
Education 0.113(0.4) -0.728 (0.2) 0.02 
FAMSQLI 0.132 (0.1) -0.133 (0.0)  0.49 
Disease 
Severity 0.130 (0.2) -0.185 (0.0) 0.42 
PHQ 
(depression 
level) 0.259 (0.1) 0.778 (0.0) 0.35 
Social 
Support 
Network (# of 
Individuals) 0.165 (0.2) -0.185 (0.002) 0.08 
Social 
Support 
Network 
(Satisfaction) 0.203 (0.1) -0.470 (0.0) 0.17 
a  Not enough other ethnicities to evaluate separately 
 
  
39
 
Table 11 
PSS regression coefficients of CCAQ and other  
variables in the variable column 
 Regression Coefficients (p-value)  
Variables C.C.A.Q. Other Variables R2 
Age 0.039 (0.7) -0.291 (0.4) 0.01 
Sex 0.000 (1.0) -3.182 (0.1) 0.02 
Ethnicity 
(Caucasian)a 0.028 (0.8) 2.713 (0.4) 0.01 
Employed 0.007 (1.0) -3.100 (0.05) 0.03 
Work 
Outside 
Home 0.008 (1.0) -2.905 (0.1) 0.03 
Income 0.049 (0.6) -0.784 (0.012) 0.05 
Education 0.038 (0.7) -0.678 (0.3) 0.01 
FAMSQLI 0.057 (0.4) -0.132 (0.0) 0.49 
Disease 
Severity 0.038 (0.6) -0.184 (0.0) 0.41 
PHQ 
(depression 
level) 0.092 (0.3) 0.759 (0.0) 0.33 
Social 
Support 
Network (# of 
Individuals) 0.084(0.4) -0.186 (0.002) 0.08 
Social 
Support 
Network 
(Satisfaction) 0.103(0.3) -0.458 (0.0) 0.15 
a  Not enough other ethnicities to evaluate separately 
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A significant interaction occurred with LES as the dependent variable and pet 
ownership and household income serving as the independent variables.  See graph in 
figure 12. 
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Fig. 12.  Interaction graph of LES score with income and pet ownership 
 
 
 
Disease Severity Components 
The questions that comprised the disease severity score were taken as a subset of 
the FAMSQLI questionnaire.  The factor analysis for the questions that comprise the 
disease severity score revealed that 39% of the variance could be explained within the 
first component.  See tables 12 and 13 for factor analysis data. 
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Table 12 
Factor analysis for questions that comprise the disease severity score: total variance 
explained 
 Initial EigenValues Extraction Sums of Squared Loadings
Component Total % of Variance Cumulative % Total % of Variance Cumulative % 
1 14.019 38.943 38.94259 14.019 38.943 38.943 
2 2.184 6.065 45.00787 2.184 6.065 45.008 
3 1.859 5.165 50.17256 1.859 5.165 50.173 
4 1.590 4.417 54.58987 1.590 4.417 54.590 
5 1.543 4.286 58.87616 1.543 4.286 58.876 
6 1.376 3.822 62.69861 1.376 3.822 62.699 
7 1.220 3.390 66.08851 1.220 3.390 66.089 
8 1.040 2.890 68.97868 1.040 2.890 68.979 
9 .919 2.551 71.53012    
10 .881 2.446 73.9766    
11 .852 2.366 76.34244    
12 .761 2.114 78.45605    
13 .660 1.835 80.29058    
14 .638 1.772 82.06297    
15 .608 1.688 83.75127    
16 .570 1.584 85.33538    
17 .533 1.481 86.81613    
18 .519 1.443 88.25912    
19 .499 1.386 89.64552    
20 .439 1.220 90.8651    
21 .409 1.137 92.00178    
22 .349 .969 92.97118    
23 .331 .919 93.89048    
24 .306 .851 94.74108    
25 .276 .766 95.50733    
26 .248 .688 96.19509    
27 .241 .669 96.86424    
28 .214 .596 97.46    
29 .177 .492 97.9517    
30 .151 .420 98.37165    
31 .141 .391 98.76278    
32 .116 .323 99.08588    
33 .099 .276 99.36167    
34 .088 .245 99.60654    
35 .086 .240 99.84623    
36 .055 .154 100    
Extraction Method: Principal Component Analysis. 
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The factors within the first component were all above 0.3 with the exception of the 
question referring to sexually active status within the last 12 months.  The Cronbach’s 
alpha of the disease severity questions was 0.94 indicating that these questions combined 
together to make a disease severity score expressed a high internal reliability.      
 
Table 13 
Factor analysis for questions that comprise the disease severity score: component matrixa 
 Component 
 1 2 3 4 5 6 7 8 
@1_NEEDS 0.805 0.231 -0.036 0.130 -0.109 0.106 -0.003 -0.114 
@2_WORK 0.514 0.198 -0.066 0.072 -0.087 0.214 -0.319 0.041 
@3_WALKI 0.715 0.431 -0.028 -0.036 0.094 0.080 0.030 -0.233 
@4_SOCIA 0.807 0.231 0.078 0.230 -0.065 0.117 -0.034 0.025 
@5_LEGS 0.590 0.282 -0.165 -0.217 0.193 0.067 0.182 -0.120 
@6_GETTI 0.645 0.379 0.000 0.196 0.058 0.209 0.055 -0.164 
@7_PLANS 0.731 0.352 -0.005 0.282 -0.044 0.140 0.023 -0.093 
@8_NAUSE 0.538 -0.016 0.137 0.001 0.083 -0.066 -0.618 0.158 
@9_PAIN 0.684 0.254 0.292 -0.285 -0.148 -0.006 0.050 -0.051 
@10_SICK 0.687 0.044 0.315 -0.060 -0.095 -0.242 -0.381 0.081 
@11_WEAK 0.754 0.187 0.183 -0.128 -0.095 -0.191 -0.057 -0.099 
@12_PAIN 0.674 0.121 0.313 -0.314 -0.094 -0.056 0.012 -0.245 
@13_HEAD 0.533 -0.365 0.278 -0.112 0.103 -0.264 -0.088 -0.039 
@14_MUSC 0.419 -0.032 0.247 -0.233 -0.172 -0.068 0.088 0.102 
@29_LACK 0.785 -0.159 -0.146 0.087 -0.298 -0.201 0.257 0.011 
@30_TIRE 0.770 -0.186 -0.121 0.097 -0.301 -0.248 0.225 -0.010 
@31_TROU 0.795 -0.243 -0.172 0.087 -0.296 -0.136 0.065 -0.011 
@32_TROU 0.782 -0.155 -0.249 0.267 -0.207 -0.096 -0.041 0.076 
@33_REST 0.752 -0.166 -0.236 0.224 -0.201 -0.111 -0.032 0.000 
@34_REME 0.724 -0.346 -0.283 -0.266 0.137 0.175 -0.056 0.009 
@35_CONC 0.746 -0.357 -0.257 -0.272 0.104 0.148 -0.085 0.005 
@36_THIN 0.739 -0.329 -0.301 -0.276 0.151 0.146 -0.018 0.008 
@37_LEAR 0.684 -0.274 -0.273 -0.210 0.151 0.265 -0.103 -0.021 
@45_SIDE 0.393 -0.179 0.362 0.311 0.102 -0.096 0.230 0.312 
@46_TIME 0.721 -0.046 0.130 0.292 -0.076 -0.052 -0.206 0.002 
@48_SEXU 0.145 0.204 -0.028 -0.048 -0.336 0.452 -0.048 0.638 
@50_PROU 0.531 -0.115 0.024 0.112 0.048 0.302 0.038 -0.089 
@51_NERV 0.548 0.042 0.132 -0.090 0.070 0.002 0.426 0.174 
@52_WORR 0.492 -0.108 0.375 -0.157 0.158 0.253 0.243 0.279 
@53_SLEE 0.406 -0.224 0.286 -0.190 0.160 -0.250 -0.003 0.003 
@54_HEAT 0.457 0.074 -0.328 0.103 0.173 -0.191 0.154 0.044 
@55_CONT 0.404 0.416 -0.422 -0.018 0.392 -0.309 -0.023 0.157 
@56_URIN 0.348 0.373 -0.137 -0.022 0.453 -0.364 0.006 0.365 
@57_CHIL 0.389 -0.257 0.191 0.354 0.491 0.091 -0.065 -0.057 
@58_FEVE 0.350 -0.279 0.277 0.447 0.353 0.213 0.103 -0.114 
@59_MUSC 0.608 0.196 0.214 -0.263 0.071 0.126 0.091 -0.050 
Extraction Method: Principal Component Analysis. 
a  8 components extracted with eigenvalues >1.0. 
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Correlations 
 
 Spearman rank correlation coefficients were determined to assess the correlation 
between the dependent variables, LES and PSS.  See table 14. 
 
 
Table 14 
Spearman rank correlation coefficient of dependent variables: nonparametric 
   LES_SCOR PSS_SCOR
Spearman's rho LES_SCOR Correlation 
Coefficient 
1.000 .370a 
  Sig. (2-tailed) . .000 
  N 147 147 
 PSS_SCOR Correlation 
Coefficient 
.370a 1.000 
  Sig. (2-tailed) .000 . 
  N 147 147 
a  Correlation is significant at the .01 level (2-tailed). 
 
 
 
 Spearman rank correlation coefficients were also determined to assess the 
correlation between the independent variables.  See Table 15 for data. 
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Table 15  
Spearman rank correlation coefficients of independent variables 
   AGE SEX CAUCASIA INCOME 
Spearman's 
rho AGE Correlation Coefficient 1 -.013 .113 .329a 
  Sig. (2-tailed) . .880 .173 .000 
  N 147 147 147 147 
 INCOME Correlation Coefficient .329a .002 .123 1 
  Sig. (2-tailed) .000 .979 .137 . 
  N 147 147 147 147 
 FAMSQLI Correlation Coefficient -.058 .021 -.018 .316a 
  Sig. (2-tailed) .486 .800 .827 .000 
  N 147 147 147 147 
 DISEASE Correlation Coefficient -.061 .065 .001 .310a 
  Sig. (2-tailed) .465 .433 .994 .000 
  N 147 147 147 147 
 LES_SCOR Correlation Coefficient -.059 -.080 -.101 -.260a 
  Sig. (2-tailed) .474 .338 .221 .001 
  N 147 147 147 147 
 PSS_SCOR Correlation Coefficient -.073 -.095 .070 -.237a 
  Sig. (2-tailed) .382 .254 .397 .004 
  N 147 147 147 147 
 PHQ_SCOR Correlation Coefficient .004 -.088 .132 -.287a 
  Sig. (2-tailed) .969 .392 .198 .004 
  N 97 97 97 97 
 SSQ_SCOR Correlation Coefficient -.128 -.169b -.142 .118 
  Sig. (2-tailed) .123 .041 .086 .156 
  N 147 147 147 147 
 SSQ_SCO1 Correlation Coefficient -.088 .050 -.170b -.009 
  Sig. (2-tailed) .289 .545 .040 .917 
  N 147 147 147 147 
 CABQ_SCO Correlation Coefficient .071 -.214b -.001 .079 
  Sig. (2-tailed) .434 .018 .995 .386 
  N 122 122 122 122 
 CCAQ_SCO Correlation Coefficient .174 -.240a .041 .068 
  Sig. (2-tailed) .056 .008 .654 .458 
  N 121 121 121 121 
a  Correlation is significant at the 0.05 level (2-tailed) 
b  Correlation is significant at the 0.01 level (2-tailed 
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Table 15 Continued  
   FAMSQLI DISEASE LES_SCOR PSS_SCOR
Spearman's 
rho AGE Correlation Coefficient -.058 -.061 -.059 -.073 
  Sig. (2-tailed) .486 .465 .474 .382 
  N 147 147 147 147 
 INCOME Correlation Coefficient .316a .310a -.260a -.237a 
  Sig. (2-tailed) .000 .000 .001 .004 
  N 147 147 147 147 
 FAMSQLI Correlation Coefficient 1 .963a -.254a -.658a 
  Sig. (2-tailed) . .000 .002 .000 
  N 147 147 147 147 
 DISEASE Correlation Coefficient .963a 1 -.243a -.603a 
  Sig. (2-tailed) .000 . .003 .000 
  N 147 147 147 147 
 LES_SCOR Correlation Coefficient -.254a -.243a 1 .370a 
  Sig. (2-tailed) .002 .003 . .000 
  N 147 147 147 147 
 PSS_SCOR Correlation Coefficient -.658a -.603a .370a 1 
  Sig. (2-tailed) .000 .000 .000 . 
  N 147 147 147 147 
 PHQ_SCOR Correlation Coefficient -.632a -.626a .162 .546a 
  Sig. (2-tailed) .000 .000 0.114 .000 
  N 97 97 97 97 
 SSQ_SCOR Correlation Coefficient .369a .348a .0130 -.238a 
  Sig. (2-tailed) .000 .000 .876 .004 
  N 147 147 147 147 
 SSQ_SCO1 Correlation Coefficient .428a .359a -.162 -.414a 
  Sig. (2-tailed) .000 .000 .050 .000 
  N 147 147 147 147 
 CABQ_SCO Correlation Coefficient .016 .004 .099 .075 
  Sig. (2-tailed) .858 .966 .279 .410 
  N 122 122 122 122 
 CCAQ_SCO Correlation Coefficient .019 -.017 .175 .016 
  Sig. (2-tailed) .840 .849 .055 .863 
  N 121 121 121 121 
a  Correlation is significant at the 0.05 level (2-tailed) 
b  Correlation is significant at the 0.01 level (2-tailed 
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Table 15 Continued 
   PHQ_SCOR SSQ_SCOR SSQ_SCO1
Spearman's 
rho AGE Correlation Coefficient .004 -.128 -.088 
  Sig. (2-tailed) .969 .123 .289 
  N 97 147 147 
 INCOME Correlation Coefficient -.287a .118 -.009 
  Sig. (2-tailed) .004 .156 .917 
  N 97 147 147 
 FAMSQLI Correlation Coefficient -.632a .369a .428a 
  Sig. (2-tailed) .000 .000 .000 
  N 97 147 147 
 DISEASE Correlation Coefficient -.626a .348a .359a 
  Sig. (2-tailed) .000 .000 .000 
  N 97 147 147 
 LES_SCOR Correlation Coefficient .162 .013 -.162 
  Sig. (2-tailed) .114 .876 .050 
  N 97 147 147 
 PSS_SCOR Correlation Coefficient .546 -.238a -.414a 
  Sig. (2-tailed) .000 .004 .000 
  N 97 147 147 
 PHQ_SCOR Correlation Coefficient 1 -.260b -.246b 
  Sig. (2-tailed) . .010 .015 
  N 97 97 97 
 SSQ_SCOR Correlation Coefficient -.260b 1 .293a 
  Sig. (2-tailed) .010 . .000 
  N 97 147 147 
 SSQ_SCO1 Correlation Coefficient -.246b .293a 1 
  Sig. (2-tailed) .015 .000 . 
  N 97 147 147 
 CABQ_SCO Correlation Coefficient -.110 .087 .184b 
  Sig. (2-tailed) .336 .340 .043 
  N 78 122 122 
 CCAQ_SCO Correlation Coefficient -.051 .135 .197b 
  Sig. (2-tailed) .658 .140 .031 
  N 77 121 121 
a  Correlation is significant at the 0.05 level (2-tailed) 
b  Correlation is significant at the 0.01 level (2-tailed 
  
47
 
Table 15 Continued 
    PET_OWN CABQ_SCO CCAQ_SCO
Spearman's 
rho AGE Correlation Coefficient 0.061 0.071 0.174 
  Sig. (2-tailed) 0.463 0.434 0.056 
   N 147 122 121 
 INCOME Correlation Coefficient 0.066 0.08 0.068 
  Sig. (2-tailed) 0.429 0.386 0.458 
   N 147 122 121 
 FAMSQLI Correlation Coefficient -0.055 0.017 0.019 
  Sig. (2-tailed) 0.508 0.858 0.84 
   N 147 122 121 
 DISEASE Correlation Coefficient -0.054 0.004 -0.017 
  Sig. (2-tailed) 0.518 0.966 0.849 
   N 147 122 121 
 LES_SCOR Correlation Coefficient 0.02 0.099 0.175 
  Sig. (2-tailed) 0.806 0.279 0.055 
   N 147 122 121 
 PSS_SCOR Correlation Coefficient -0.018 0.075 0.0159 
  Sig. (2-tailed) 0.827 0.41 0.863 
   N 147 122 121 
 PHQ_SCOR Correlation Coefficient 0.008 -0.11 -0.051 
  Sig. (2-tailed) 0.935 0.336 0.658 
   N 97 78 77 
 SSQ_SCOR Correlation Coefficient -0.001 0.087 0.139 
  Sig. (2-tailed) 0.99 0.34 0.14 
   N 147 122 121 
 SSQ_SCO1 Correlation Coefficient -0.004 .184b .197b 
  Sig. (2-tailed) 0.963 0.043 0.031 
   N 147 122 121 
 CABQ_SCO Correlation Coefficient . 1 .688a 
  Sig. (2-tailed) . . 0 
   N 122 122 121 
 CCAQ_SCO Correlation Coefficient . .688a 1 
  Sig. (2-tailed) . 0 . 
   N 121 121 121 
a  Correlation is significant at the 0.05 level (2-tailed) 
b  Correlation is significant at the 0.01 level (2-tailed) 
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Interactions 
 
 The interaction term with disease severity as the dependent variable and pet 
ownership and perceived stress level as the independent variables was insignificant.  See 
table 16. 
 
Table 16 
Interaction between PSS score and pet ownership with disease severity as  
dependent variable  
Source Type III Sum 
of Squares
df Mean Square F Sig. 
Corrected Model 68402.878a 48 1425.060 3.134 0.000 
Intercept 623210.361 1 623210.361 1370.719 0.000 
PSS_SCOR 61884.007 34 1820.118 4.003 0.000 
PET_OWN 1263.558 1 1263.558 2.779 0.1 
PSS_SCOR * PET_OWN 2594.956 13 199.612 0.439 0.95 
Error 44556.632 98 454.660   
Total 1513012.000 147    
Corrected Total 112959.510 146    
a  R Squared = 0.606 (Adjusted R Squared = 0.412) 
 
 
 
The interaction term with disease severity as the dependent variable and pet ownership 
and LES score as the independent variables was also insignificant.  See table 17. 
 
Table 17 
Interaction between LES score and pet ownership with disease severity as  
dependent variable  
Source Type III Sum 
of Squares 
df Mean Square F Sig. 
Corrected Model 23485.229a 20 1174.261 1.654 0.05 
Intercept 355709.625 1 355709.625 500.920 0.000 
LES_SCOR 19303.280 12 1608.607 2.265 0.01 
PET_OWN 490.922 1 490.922 0.691 0.41 
LES_SCOR * PET_OWN  1564.848 7 223.550 0.315 0.95 
Error 89474.281 126 710.113   
Total 1513012.000 147    
Corrected Total 112959.510 146    
a  R Squared = 0.208 (Adjusted R Squared = 0.082) 
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Type of Pet Owned 
There were 21 patients that owned only cats and 101 patients that owned a dog, a 
dog and cat, and a dog and other animal.  There were very few people who owned a pet 
other than a dog or cat, but the people who owned other animals also owned dogs. The 
Mann-Whitney test revealed that there was not a significant difference in attachment 
levels for either questionnaire, CABQ or CCAQ, according to the type of pet that was 
owned.  See tables 18 and 19. 
 
Table 18 
Significant test for attachment level (defined by the CABQ score) of cat owners vs. dog  
and/or all others 
Test Statisticsa 
 CABQ_SCO
Mann-Whitney U 806.000 
Wilcoxon W 1037.000 
Z -1.730 
Asymp. Sig. (2-tailed) 0.08 
a  Grouping Variable: CAT 
 
 
 
Table 19 
Significant test for attachment level (defined by the CCAQ score) of cat owners vs. dog  
and/or all others 
Test Statisticsa 
 CCAQ_SCO
Mann-Whitney U 915.000 
Wilcoxon W 1125.000 
Z -0.676 
Asymp. Sig. (2-tailed) 0.5 
a  Grouping Variable: CAT 
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Younger Age Group 
 The younger age group of 18-43 did not experience significant effects on their 
LES and PSS scores from pet ownership and attachment.  See tables 20 and 21. 
 
Table 20 
LES regression coefficients  
Variable 
Regression 
Coefficient 
of Variable P-value R2 
Age (18-43)  -0.087 0.67 0.002 
Pet Ownership and Age 0.567 0.357 0.014 
CABQ and Age 0.025 0.571 0.005 
CCAQ and Age 0.034 0.363 0.014 
 
 
 
Table 21 
PSS regression coefficients  
Variable 
Regression 
Coefficient 
of Variable P-value R2 
Age (18-43) 0.924 0.171 0.024 
Pet Ownership and Age -0.558 0.784 0.025 
CABQ and Age 0.086 0.58 0.038 
CCAQ and Age 0.019 0.882 0.036 
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DISCUSSION AND CONCLUSIONS 
 
Previous studies have found that pet ownership and attachment have positive 
influences on peoples’ stress levels.  In this study our objective was find if this was true 
for MS patients in the relapsing-remitting stage of MS, since stress has negative impacts 
on them.  In this study, pet ownership and attachment were not significantly related to 
the stress level of MS patients.   
The median age for the study population for both pet owners and non-pet owners 
was 39-43 years.  The age distribution was consistent with other studies of patients in the 
relapsing remitting stage (Ackerman et al., 2002; Mohr et al., 2000).  As with most 
autoimmune diseases, it was not surprising to find that the majority of the participants 
were female.  The most prevalent ethnicity of our population was Caucasian.  The 
employment rate of pet owners versus non-pet owners was similar.  Of the pet owners, 
more than 65% worked outside the home.  There was relatively equal percent of non-pet 
owners who worked outside the home compared to those who did not.  A large number 
of MS patients surveyed in this study reported a household income of $105,000 or 
greater.  Other studies report that MS has characteristically been associated with higher 
socioeconomic status (Lauer, 1994; Pryse-Phillips, 1996).  Also, the majority of the 
patients surveyed had at least some college education.  Interesting, but not significant, 
more non-pet owners have seen a counselor as opposed to pet owners. 
The dependent variables were the perceived stress level in the last month 
designated by the PSS score and the number of negative life events experienced within 
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the last 12 months determined by the LES score.  The PSS score was normally 
distributed among the study population with a mean score of 17.7.  The observed scores 
for the PSS ranged across most of the range of a possible PSS score of 1 to 36. Mohr 
used the Profile of Mood States (POMS) to evaluate psychological stress and reported a 
mean score of 51.19 with a range of 4 to 176, which corresponds to a lower stress level 
compared to the current study (Mohr et al., 2000).  The LES was not normally 
distributed with a mean score of 3.5 and a median of 3.0.  Ackerman reported that 
subjects averaged 1.6 negative life events per year ((Ackerman et al., 2002) and Mohr 
reported and average of 1.38 negative life events (Mohr et al., 2000) in his study 
population.  The patients in our study experienced slightly more negative life events than 
reported in other studies.  A box-cox analysis was run on the LES to see if a 
transformation would be beneficial.  The box-cox analysis suggested that the LES values 
be raised to the 0.40.  After raising the values to 0.40 a test of normality revealed that the 
LES was still not normally distributed.  So, regression analysis proceeded with the 
original LES score.  A nonparametric correlation between PSS and LES revealed a 
small, but significant correlation between the two variables.  The low correlation value 
indicated that the two questionnaires were not assessing the same item; hence the 
regression analyses were fit separately.   
The main exposure variables in this study were pet ownership status within the 
past 12 months and the attachment level the MS patient experienced to their companion 
pet, defined by their CABQ and CCAQ scores.  The majority of MS patients in this 
study owned a companion animal.  Of the participants that owned a companion animal, 
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most reported that they were highly attached.  The CABQ and CCAQ were highly 
correlated, indicating that they assessed the same type of attachment information and our 
results demonstrated consistency between the two.  The majority of MS patients in this 
study demonstrated a high level of attachment to their pet.    
The FAMSQLI determined the patients’ quality of life and reported an average 
score of 164.3 with over half of the patients experiencing a score of 176 or above.  Most 
patients had a relatively good quality of life.  The disease severity score had a mean 
score of 97.6 and a median of 103, indicating that our study population experienced a 
high level of disability.  Despite the severity of their disease the majority of patients 
managed to maintain a good outlook on life and viewed life events as positive.  The 
PHQ score for the study population exhibited a mean of 6.8 representing that most of the 
patients experienced low levels of depressed feelings.  Two measures of social support 
were calculated.  The first was the SSQ based on the number of individuals that the 
patient had available to them for social support.  The second was the SSQ based on the 
satisfaction of the support provided by the individuals.  The SSQ level based on 
satisfaction was higher overall than the SSQ based on number of individuals.  No 
relationship between pet attachment and social support based on satisfaction or number 
of individuals was significant, indicating regardless of the patients' social support status 
it did not influence their pet attachment level.   
Linear regression was conducted on the independent variables individually with 
each dependent variable.  Only 4 independent variables were found to be significantly 
associated with the LES score with a p-value of <0.05.  The significant independent 
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variables associated with LES consisted of income, FAMSQLI score, disease severity 
score, PHQ score, and SSQ score based on satisfaction.  An increase in income had a 
decrease in number of negative life events by 0.3.  Fewer negative life events were 
associated with a better quality of life.  As disease severity changed so did the number of 
negative life events by 0.024.  It was not surprising to find that the disease severity score 
was also significant due to the fact that it was a subset of the FAMSQLI.  As the number 
of negative life events a patient experienced increased so did their depression level by 
0.114.  The satisfaction experienced from their social network was associated with a 
decrease in number of negative life events.  Neither pet ownership nor the attachment 
variables were significantly associated with LES.   
Multiple linear regression was performed with LES as the dependent variable 
with pet ownership being forced into the model and each remaining independent variable 
inserted into the model individually.  The variables that changed the coefficient of pet 
ownership and/or the other variables noticeably were evaluated for linearity and 
interaction.  Some variables changed the sign of the coefficient, but pet ownership 
continued to be not significantly associated with LES.  The interaction term was also not 
significant.  Possible explanations consisted of an unstable model due to few non-pet 
owners or a small amount of confounding.  The household income variable had a 
significant interaction with pet ownership.  The interaction indicated that people with a 
high income who owned a pet had a higher LES score compared to those who did not 
own a pet.  Those that had a lower income and owned pets had lower LES scores 
indicating that having a pet did help with the way they viewed life events.  LES was 
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evaluated as the dependent variable with either CABQ or CCAQ included.  The other 
independent variables were inserted separately and no relevant changes in the regression 
coefficients were identified.  No interactions were found to be significant.   
Multiple linear regression was also performed with PSS as the dependent 
variable and pet ownership included with each additional independent variable inserted 
into the model individually.  The majority of the variables were significantly associated 
with the PSS score with the exception of age, sex, ethnicity, and the pet associated 
variables.  A positive change in employment, work outside of the home status, income, 
education, quality of life, disease severity, and social support based on number of 
individuals and satisfaction were all associated with a small decrease in PSS.  An 
increase in depression levels resulted in an increase in PSS scores by 0.752.  As with the 
LES scores, the PSS scores resulted in no important changes noted in the regression 
coefficients of the independent variables.  Therefore, pet ownership and attachment did 
not exhibit an influence on stress levels of MS patients in this study.   
In order to evaluate the effect of stress and pets on disease severity, additional 
models were examined.  An interaction term composed of disease severity as the 
dependent variable with pet ownership and perceived stress level as the independent 
variables was not significant.  Also, the interaction term with disease severity as the 
dependent variable with pet ownership and number of negative life events as predictor 
variables was not significant.  Therefore, pet ownership did not influence the patients' 
disease severity significantly. 
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The type of pet owned whether it was a cat only or a dog, a dog and cat, or a dog 
and other animal did not differ significantly with level of attachment.  Thus, the type of 
pet the patient owned did not influence their attachment levels.  A box and whisker plot 
revealed that cat owners exhibited a narrower range of attachment levels versus dog 
owners.   
Since earlier stages of disease might fluctuate more, a younger age group of MS 
patients was considered to evaluate if pet ownership and attachment had an effect on 
their LES and PSS scores.  This study did not find that the younger population 
experienced significant decreases in their LES and PSS scores as a result of pet 
ownership and attachment levels.      
The results of this study did not support our hypothesis.  Pet ownership and/or 
attachment did not have a positive effect on MS patients’ stress levels in the relapsing- 
remitting stage.  These results were not expected since pet ownership has previously 
been shown to alleviate stress, lower blood pressure, and decrease heart rate in other 
populations.   
Strengths and Limitations 
Even though the UTSN clinic is a specialty neurology clinic it still provides care 
for those not able to pay, which allowed this study to obtain a representative sample 
based on income.  Though, no causal interferences can be drawn from cross-sectional 
studies, they can provide an application in planning for health care.  Since this study 
only recruited participants from the UTSN clinic, selection biases exist in that not every 
MS patient had an equal chance of being selected for the study.  Selection bias could 
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have existed because the surveys were only being administered in English, but all of our 
possible respondents spoke English so this was not a problem.  Non-respondent bias was 
minimal due to only 2 people choosing not to participate, but information regarding 
them was not obtainable.  Limitations were placed on external reliability because the 
specific sampling frame did not represent the entire population of MS patients or a 
random sample of them.  The sampling frame was limited to patients of the UTSN clinic 
in Dallas, TX.  We speculated since this population had a relatively high education level 
they were able to obtain jobs that paid a higher income.  Those that did not work, but 
reported a large household income, must have had a significant other that was able to 
pay the medical expenses for them.  We are not sure why there were so few respondents 
that did not own pets, but our thoughts are that most of the respondents could afford pets 
and a larger income could lead to a bigger house with a yard that could accommodate 
pets.  Also, Dallas is a metropolitan area with many surrounding towns and cities 
consisting of rural areas that enable people to have pets.     
The sample size of this study was not an optimal sample size.  The original goal 
was to obtain 300-400 participants, but due to time constraints this was not possible.  
Not enough non-pet owners responded or existed within the study population making it 
difficult to have a representative sample.  Though it applied to very few questionnaires, 
some surveys included in the questionnaire were not filled out resulting in missing data. 
This study did not take into account the use of disease modifying drugs such as 
Interferon-β and Copaxone® which could have impacted our study results especially 
disease severity. 
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Recommendations 
Recommendations for future studies include an increase in sample size.  This 
study lacked a large enough number of patients that did not own pets.  Also, surveying 
more clinics to obtain a more representative sample of the MS population should prove 
beneficial.  It would have been valuable to know if the patients were having a relapse at 
time of filling out the questionnaire to evaluate if the relapse had an effect on their 
perceived stress level.  Also, knowledge of how long the patient had been diagnosed and 
how long the patient thought they had MS would be advantageous to determine if the 
time of diagnosis is associated with stress levels.  In addition, the use of antidepressant 
drugs could have an effect on the patients' depression level, which in turn could affect 
their stress level.  Therefore, having data regarding the use of antidepressant drugs could 
add to the analysis of stress levels.  This study also did not obtain information regarding 
marital status.  Future studies should address this issue because people with partners 
have been shown to experience less stress compared to those without partners (Mohr et 
al., 2002). 
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APPENDIX 
 
INTRODUCTORY LETTER AND SURVEY 
 
 
Dear Sir/Madam, 
 
We are conducting a study to evaluate how life events influence MS onset and relapses 
and possible methods for lowering stress.  We are asking for your participation in filling 
out the enclosed surveys.  It will take approximately 30 minutes for you to fill them out.  
Once you have completed the surveys give them to your doctor so that he may indicate 
what stage of MS you are currently in.  You or your doctor will then place the surveys in 
the box for completed surveys.  Please do not put your name or any personal identifying 
information on the survey.  They are completely anonymous.  If you choose not to 
participate, please check the box on the first page that reads “I chose not to participate”.  
If at any time you feel uncomfortable about the questions you do not have to continue.  
If you feel distressed or upset please notify your doctor.  We appreciate your time and 
participation in helping us conduct this study.  Once the study is complete, results will be 
sent to your doctor’s office for you to read.  If you have any questions you may ask the 
staff at the clinic or contact me.  My contact information is: 
 
Ashley Loven, BS, MS degree candidate 
Phone:  979-696-5310 
E-mail:  aloven@cvm.tamu.edu 
Address:  Department of Veterinary Anatomy and Public Health 
College of Veterinary Medicine  
Texas A&M University 
College Station, TX 77843-4458 
 
Remember the survey is anonymous!  Neither we nor your doctor will know your 
personal responses to the survey.  Please answer truthfully to the best of your 
knowledge and ability. 
 
Please take a few minutes to fill out and hand in the survey.  The information you 
provide now may benefit MS patients for years to come.  Thank you! 
 
Sincerely, 
 
 
 
Ashley M. Loven    Margaret Slater DVM, PhD 
Graduate Student    Associate Professor 
Texas A&M University   mslater@cvm.tamu.edu (979) 845-3286 
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Have your doctor indicate what stage of Multiple Sclerosis you are 
currently in: 
 
ڤ  Benign MS 
         Patients have very few relapses with only mild symptoms.  Between these relapses, 
patients recover completely and the disease never progresses beyond a mild level of 
disability. 
 
ڤ  Relapsing-remitting MS 
         The patient experiences relapses of the disease.  Afterward, the patient recovers 
either partially or completely.  Disability can get worse over time. 
 
ڤ  Secondary Progressive MS 
         Starts out as relapsing-remitting MS, but gets worse with or without relapses.  
  
 
ڤ  Primary Progressive MS 
        Continually worsens with no real relapses or recoveries.  A patient’s MS may 
proceed in this way from the beginning; there may be temporary minor improvements 
and occasional periods in which the disease does not get worse. 
 
ڤ  Progressive-relapsing MS 
        Disability worsens progressively over time, as in primary progressive MS.  There 
are also periods of worsening symptoms, as in relapsing-remitting MS, but lost function 
does not return afterward. 
 
 
______________________________                                   ______________________ 
Dr. Signature                 Date 
 
 
 
 
Please check the following box if you do not wish to participate in the survey: 
 
ڤ  I chose not to participate. 
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General Information 
 
 
1.  Please indicate your age range: 
 
ڤ 18-23  ڤ  24-28 ڤ  29-33 ڤ  34-38 ڤ  39-43 ڤ  44-48 
 
ڤ  49-53 ڤ  54-58 ڤ  59-63 ڤ  64-68 ڤ  69-73 ڤ  74-78 
 
ڤ  79-83 ڤ  84-88 ڤ  89-93 ڤ  94-98 ڤ  99+ 
 
2.  ڤ  Male ڤ  Female 
 
3.  Ethnicity 
 
ڤ  Caucasian ڤ  African American ڤ  Hispanic  ڤ  Asian 
 
ڤ  Other:  ______________________________________ 
 
4.  Are you employed? 
 
ڤ  Yes  ڤ  No 
 
5.  Do you work outside the home?   
 
ڤ  No   ڤ  Yes: Job title:____________________________ 
 
6.  Household income range: 
 
ڤ  0-15,000                ڤ  15,001-30,000       ڤ  30,001-45,000         ڤ  45,001-60,000 
        
ڤ  60,001-75,000       ڤ  75,001-90,000       ڤ  90,001-105,000       ڤ  105,000+  
 
7.  Education 
 
ڤ  Finished ___ grade  ڤ  Graduated High School ڤ  GED  
ڤ  Some College  ڤ  Bachelor’s Degree  
ڤ  Some Grad. School ڤ  Graduate Degree (specify)____________ 
 
8.  Have you ever seen a psychologist or counselor before? 
 
ڤ  Yes  ڤ  No 
 
**Please do not put your name on this survey.  Neither we nor your doctor need to know who this personal 
information pertains to!  This is to ensure that the information you provide remains anonymous and 
unidentifiable. 
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F.A.M.S.Q.L.I. 
 
Please indicate how true each statement has been for you during the 
past 7 days. 
 
 
 
Mobility             not        a little         some-    quite        very 
             at all           bit  what   a bit       much 
 
1.  Because of my physical condition,  
I have trouble meeting the needs of my family……………  0                1                2                3                4 
 
2.  I am able to work (include work in home)……………..  0                1                2                3                4 
 
3.  I have trouble walking………………………………….  0                1                2                3                4 
 
4.  I have to limit my social activity because of my……….  0                1                2                3                4 
condition 
 
5.  My legs are strong……………………………………… 0                1                2                3                4 
 
6.  I have trouble getting around in public places………….  0                1                2                3                4 
 
7.  I have to make plans around my condition……………..  0                1                2                3                4 
 
                                    Symptoms                                          not        a little        some-        quite        very 
                                                                                              at all          bit            what         a bit       much 
 
8.  I have nausea (vomiting sensations)……………….......  0                1                2                3                4 
 
9.  I have pain……………………………………………… 0                1                2                3                4 
 
10.  I feel sick……………………………………………...  0                1                2                3                4 
 
11.  I feel weak all over……………………………………  0                1                2                3                4 
 
12.  I have pain in my joints……………………………….  0                1                2                3                4 
 
13.  I am bothered by headaches…………………………..  0                1                2                3                4 
 
14.  I am bothered by muscle pains………………………..  0                1                2                3                4 
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                                    Emotional Well-Being                      not        a little        some-        quite        very 
                                                                                              at all          bit            what         a bit       much 
 
15.  I feel sad……………………………………………...  0                1                2                3                4 
 
16.  I am losing hope in the fight against my illness……… 0                1                2                3                4 
 
17.  I am able to enjoy life………………………………...  0                1                2                3                4 
 
18.  I feel trapped by my condition………………………..  0                1                2                3                4 
 
19.  I am depressed about my condition…………………..  0                1                2                3                4 
 
20.  I feel useless…………………………………………..  0                1                2                3                4 
 
21.  I feel overwhelmed by my condition…………………  0                1                2                3                4 
 
                                    General Contentment                       not        a little        some-        quite        very 
                                                                                              at all          bit            what         a bit       much 
 
22.  My work (include work in home) is fulfilling………..  0                1                2                3                4 
 
23.  I have accepted my illness……………………………  0                1                2                3                4 
 
24.  I am enjoying the things I usually do for fun………...  0                1                2                3                4     
 
25.  I am content with the quality of my life right now…..  0                1                2                3                4 
 
26.  I am frustrated by my condition……………………...  0                1                2                3                4 
 
27.  I feel a sense of purpose in my life…………………..  0                1                2                3                4 
 
28.  I feel motivated to do things………………………….  0                1                2                3                4 
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                                    Thinking and Fatigue                       not        a little        some-        quite        very 
                                                                                              at all          bit            what         a bit       much 
 
29.  I have a lack of energy……………………………….  0                1                2                3                4 
 
30.  I feel tired……………………………………………   0                1                2                3                4 
 
31.  I have trouble starting things because I am tired…….  0                1                2                3                4 
 
32.  I have trouble finishing things because I am tired…...  0                1                2                3                4 
 
33.  I need to rest during the day…………………………  0                1                2                3                4 
 
34.  I have trouble remembering things………………….   0                1                2                3                4     
 
35.  I have trouble concentrating…………………………  0                1                2                3                4 
 
36.  My thinking is slow………………………………….  0                1                2                3                4 
 
37.  I have trouble learning new tasks or directions……...  0                1                2                3                4 
 
                                    Family/Social Well-Being                not        a little        some-        quite        very 
                                                                                              at all          bit            what         a bit       much 
 
38.  I feel distant from my friends………………………..  0                1                2                3                4 
 
39.  I get emotional support from my family…………….  0                1                2                3                4 
 
40.  I get support from my friends and neighbors………..  0                1                2                3                4 
 
41.  My family has accepted my illness………………….  0                1                2                3                4 
 
42.  Family communication about my illness is poor……  0                1                2                3                4 
 
43.  My family has trouble understanding  when my 
condition gets worse……………………………………...  0                1                2                3                4 
 
44.  I feel “left out” of things……………………………..  0                1                2                3                4 
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                                    Additional Concerns                        not        a little        some-        quite        very 
                                                                                              at all          bit            what         a bit       much 
 
45.  I am bothered by side effects of treatment……….......  0                1                2                3                4 
 
46.  I am forced to spend time in bed..................................  0                1                2                3                4 
 
47.  I feel close to my partner (or the person who is my  
main support)......................................................................  0                1                2                3                4 
                              
48.  Have you been sexually active during the past year? 
No___ Yes___  If yes: I am satisfied with my sex life.......  0                1                2                3                4 
 
49.  My doctor is available to answer my questions...........  0                1                2                3                4 
 
50.  I am proud of how I am coping with illness................  0                1                2                3                4 
 
51.  I feel nervous...............................................................  0                1                2                3                4 
 
52.  I worry that my condition will get worse....................  0                1                2                3                4 
 
53.  I am sleeping well.......................................................  0                1                2                3                4 
 
54.  Heat worsens my symptoms.......................................  0                1                2                3                4 
 
55.  I lose control of my urine............................................  0                1                2                3                4 
 
56.  I urinate more frequently than usual...........................  0                1                2                3                4 
 
57.  I am bothered by the chills..........................................  0                1                2                3                4 
 
58.  I am bothered by fevers...............................................  0                1                2                3                4 
 
59.  I am bothered by muscle spasms.................................  0                1                2                3                4 
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L.E.S. 
 
 
The following questions deal with positive or negative stress events present at the time of onset or 
exacerbations of Multiple Sclerosis in your life.  Please answer the questions according to the stress events 
that occurred in the past 12 months.  If an event did occur check yes and rate it if applicable (indicated 
by rating scale), and if an event did not occur check no. 
In the last 12 months….. 
 
1.  Have you moved? 
No [  ]      Yes  [  ] 
 
Overall, would you say that your moving was a good or bad experience? 
 
___very good (1)   ___slightly bad (4) 
___moderately good (2)  ___moderately bad (5) 
___slightly good (3)  ___very bad (6) 
 
2.  Have you broken off an engagement to be married or ended an intimate relationship? 
No [  ]      Yes  [  ] 
 
How would you rate your feelings about breaking up? 
 
___very good (1)   ___ slightly bad (4) 
___moderately good (2)  ___moderately bad (5) 
___slightly good (3)  ___very bad (6) 
 
3.  Did you get married in the last 12 months?  
No [  ]      Yes  [  ] 
 
Overall, would you rate getting married as a good or bad experience? 
 
___very good (1)   ___slightly bad (4) 
___moderately good (2)  ___moderately bad (5) 
___slightly good (3)  ___very bad (6) 
 
4.  Did someone you were close to die during the last 12 months? 
No [  ]      Yes  [  ] 
 
5.  Were you separated or divorced during the last 12 months? 
No [  ]      Yes  [  ] 
 
Overall, would you rate your separation or divorce as a good or bad experience? 
 
___very good (1)   ___slightly bad (4) 
___moderately good (2)  ___moderately bad (5) 
___slightly good (3)  ___very bad (6) 
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6.  Did you break up with a close friend during the last 12 months? 
No [  ]      Yes  [  ] 
 
Overall, would you rate breaking up as a good or bad experience? 
 
___very good (1)   ___ slightly bad (4) 
___moderately good (2)  ___moderately bad (5) 
___slightly good (3)  ___very bad (6) 
 
7.  Have you had any important relationship, for example, with your spouse, a close friend, your boss, or a 
family member become significantly worse during the last 12 months (this should not include the 
relationship referred to in item 6 above)? 
 No [  ]      Yes  [  ] 
 
8.  Did you have a child or adopt a child during the last 12 months? 
No [  ]      Yes  [  ] 
 
Overall, would you rate having a child and adjusting to having a child as a good or bad 
experience? 
 
___very good (1)   ___slightly bad (4) 
___moderately good (2)  ___moderately bad (5) 
___slightly good (3)  ___very bad (6) 
 
9.  Have you, a very close friend, or close family member had an accident that required emergency 
medical treatment during the last 12 months? 
 No [  ]      Yes  [  ] 
 
10.  Have you, a very close friend, or close family member been hospitalized for a serious (life 
threatening) illness during the last 12 months? 
 No [  ]      Yes  [  ] 
 
11a.  (Women) Have you been pregnant during the last 12 months? 
 No [  ]      Yes  [  ] 
 
 How would you rate being pregnant? 
 
___very good (1)   ___slightly bad (4) 
___moderately good (2)  ___moderately bad (5) 
___slightly good (3)  ___very bad (6) 
 
11b.  (men)  Has your wife, partner, or girlfriend been pregnant during the last 12 months?  (Check NO if 
you do not have a wife, partner, or girlfriend.) 
 No [  ]      Yes  [  ] 
 
 How do you feel about the pregnancy? 
 
___very good (1)   ___slightly bad (4) 
___moderately good (2)  ___moderately bad (5) 
___slightly good (3)  ___very bad (6) 
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12a.  (Women) Have you had an abortion during the last 12 months? 
 No [  ]      Yes  [  ] 
 
12b.  (Men)  Has your wife, partner, or girlfriend had an abortion during the last 12 months?  (Check NO 
if you do not have a wife, partner, or girlfriend.) 
 No [  ]      Yes  [  ] 
 
13a.  (Women) Have you had a miscarriage or stillbirth during the last 12 months? 
 No [  ]      Yes  [  ] 
 
13b.  (Men)  Has your wife, partner, or girlfriend had miscarriage or stillbirth during the last 12 months?  
(Check NO if you do not have a wife, partner, or girlfriend.) 
 No [  ]      Yes  [  ] 
 
14.  Have you or your spouse/partner lost or changed jobs or been involuntarily unemployed  during the 
last 12 months? 
 No [  ]      Yes  [  ] 
 
 How would you rate your feelings about leaving your job? 
 
___very good (1)   ___slightly bad (4) 
___moderately good (2)  ___moderately bad (5) 
___slightly good (3)  ___very bad (6) 
 
15.  During the last 12 months, have you or your spouse/partner suffered a significant business or 
investment loss or has a business you owned failed? 
 No [  ]      Yes  [  ] 
 
16.  During the last 12 months, have you or your spouse/partner had any serious problems or 
disappointment at work or in an educational course (university, training program, etc.)?  
 No [  ]      Yes  [  ]  
 
17.  Have you or your spouse/partner had significant success at work or in an educational course 
(university, training program, etc.) during the last 12 months? 
 No [  ]      Yes  [  ] 
 
18.  Has there been significant change in your personal finances during the last 12 months? 
 No [  ]      Yes  [  ] 
 
19.  Has your house been broken into and/or burglarized during the last 12 months? 
 No [  ]      Yes  [  ] 
 
20.  Have you or your spouse/partner or other member of your immediate family been assaulted or 
mugged during the last 12 months? 
 No [  ]      Yes  [  ] 
 
21.  Has the behavior of any member of your family been a significant problem for you during the last 12 
months? 
 No [  ]      Yes  [  ] 
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22.  Have you or your spouse/partner had to appear in court during the last 12 months as either a 
defendant, a witness in a criminal case, or as party to a suit? 
 No [  ]      Yes  [  ] 
 
 How would you rate the court experience? 
 
___very good (1)   ___slightly bad (4) 
___moderately good (2)  ___moderately bad (5) 
___slightly good (3)  ___very bad (6) 
 
23.  Have you had a pet (animal) to whom you were attached die, or get lost, or did you have to give it 
away during the last 12 months? 
 No [  ]      Yes  [  ] 
 
24.  Other than the events we have already asked about, have any other important things happened to you 
or to a very close friend or close family member in the last 12 months that made that period significantly 
different from a typical year? 
 No [  ]      Yes  [  ] 
 
 How would you rate your feelings about this experience? 
 
___very good (1)   ___slightly bad (4) 
___moderately good (2)  ___moderately bad (5) 
___slightly good (3)  ___very bad (6) 
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P.S.S. 
 
The questions in this section ask you about your feelings and thoughts during the last month.  In each 
case, please circle how often you felt or thought a certain way. 
 
 
          never     almost     some-     fairly  very   
            never      times      often  often  
   
1.  In the last month, how often have you  1   2  3   4       5  
become upset because of something that 
happened unexpectedly? 
 
2.  In the last month, how often have you  1   2  3   4       5  
felt that you were unable to control the  
important things in your life? 
 
3.  In the last month, how often have you  1   2  3   4       5  
felt nervous and “stressed”? 
 
4.  In the last month, how often have you  1   2  3   4       5  
felt confident about your ability to handle  
your personal problems? 
 
5.  In the last month, how often have you  1   2  3   4       5  
felt that things were going your way? 
 
6.  In the last month, how often have you  1   2  3   4       5  
found that you could not cope with all the  
things that you had to do? 
 
7.  In the last month, how often have you  1   2  3   4       5  
been able to control irritations in your life? 
 
8.  In the last month, how often have you  1   2  3   4       5  
felt that you were on top of things? 
 
9.  In the last month, how often have you  1   2  3   4       5  
been angered because of things that were  
outside of your control? 
 
10.  In the last month, how often have you  1   2  3   4       5  
felt difficulties were piling up so high that  
you could not overcome them? 
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P.P.Q. 
 
 
 
The following questions concern your mood.  In the last 2 weeks how often have you been bothered 
by any of the following... 
 
      Not    Several     More than      Nearly   
at all      days          half the     every 
                       days      day 
       
1.  Little interest or pleasure in doing things?    1         2                 3        4 
 
2.  Feeling down, depressed, or hopeless?     1         2                 3        4  
 
3.  Trouble falling or staying asleep or sleeping  
too much?        1         2                 3        4 
 
4.  Feeling tired or having little energy?     1         2                 3        4  
 
5.  Poor appetite or overeating?      1         2                 3        4 
 
6.  Feeling bad about yourself – or that you  
are a failure or have let yourself or your  
family down?         1         2                 3        4 
 
7.  Trouble concentrating on things, such  
as reading the newspaper or watching television?            1         2                 3        4 
 
8.  Moving or speaking so slowly that        
other people have noticed?  Or the opposite –  
being so fidgety or restless that you were  
moving around a lot more than usual?       1         2                 3        4 
 
9.  In the last 2 weeks, have you had thoughts  
that you would be better off dead or of hurting  
yourself in some way?         1         2                 3        4
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S.S.Q. 
 
 
The following ask about people in your environment who provide you with help or support.  Each question 
has two parts.  (1) Under each question, list the individuals of all the people you know, excluding yourself, 
whom you can count on for help or support for the item.  You may either give the person’s initials or their 
relationship to you.  Do not list more than 9 individuals for each item.  (2) For the second part of each 
question, please circle how satisfied you are with the overall support available to you for each item.   
 
0 = Very Dissatisfied  to  5 = Very Satisfied. 
 
 
1.  Who can you really count on to distract you from your worries when you feel under stress?     
Initials: ______________________________________________________________________ 
 
How satisfied are you with the support available to you in this area? 0-----1-----2-----3-----4-----5 
 
2.  Whom can you really count on to help you feel more relaxed when you are under pressure or 
tense?   
Initials: _______________________________________________________________________   
 
How satisfied are you with the support available to you in this area? 0-----1-----2-----3-----4-----5 
 
3.  Who accepts you totally, including both your worst and your best points? 
Initials: _______________________________________________________________________ 
 
How satisfied are you with the support available to you in this area? 0-----1-----2-----3-----4-----5 
 
4.  Whom can you really count on to care about you, regardless of what is happening to you? 
Initials: _______________________________________________________________________ 
 
How satisfied are you with the support available to you in this area? 0-----1-----2-----3-----4-----5 
 
5.  Whom can you really count on to help you feel better when you are generally down in the 
dumps?   
Initials: _______________________________________________________________________ 
 
How satisfied are you with the support available to you in this area? 0-----1-----2-----3-----4-----5 
 
6.  Whom can you really count on to console (comfort) you when you are very upset? 
Initials: _______________________________________________________________________ 
 
How satisfied are you with the support available to you in this area? 0-----1-----2-----3-----4-----5 
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C.A.B.Q. 
 
The following questions ask you about the quality of your relationship or social interaction with your pet 
or companion animal.  In each case, please circle how often the interaction occurred.  If you answer NO to 
the first two questions leave the rest of the responses and next page blank.   
 
 
1.  Do you presently own a pet or companion animal? 
 ___Yes    ___No 
 
2.  In the past 12 months, did you own a pet or companion animal? 
 ___Yes    ___No 
 
If the answer to the above 2 questions is NO you are done with the survey.   
If the answer to one of them is YES please continue. 
THANK YOU FOR YOUR TIME! 
     ↓ 
3.  What kind of pet or companion animal do you or have you owned/interacted with in the past 12 
months? 
 ___Dog    ___Cat    ___Horse    ___Rabbit    ___ Rodent    ___Reptile    ___Other 
 
                                                                                  Never      Rarely        Often         Generally     Always 
 
4.  How often are you responsible for your    1    2        3              4                  5 
companion animal’s care? 
 
5.  How often do you clean up after your  1    2        3              4       5 
 companion animal? 
 
6.  How often do you hold, stroke, or pet  1    2        3              4       5 
 your companion animal? 
 
7.  How often does your companion animal  1    2        3               4       5 
sleep in your room? 
 
8.  How often do you feel that your   1    2        3               4       5 
companion animal is responsive to you? 
 
9.  How often do you feel that you have a close 1    2        3               4       5 
 relationship with your companion animal? 
 
10.  How often do you travel with your   1    2        3               4       5 
companion animal? 
 
11.  How often do you sleep near your  1    2        3  4       5 
companion animal?               
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C.C.A.Q. 
 
Please answer the following questions by rating your response with a 1-4 scale. 
 
 
               strongly                                        strongly 
         disagree     disagree      agree       agree 
 
   1.  My pet provides me with companionship.             1                2                  3             4 
    
   2.  Having a pet gives me something to care for.   1                2                 3             4       
 
   3.  My pet provides me with pleasurable activity.       1                2                 3             4 
 
   4.  My pet is a source of constancy in my life.   1                2                 3             4 
 
   5.  My pet makes me feel needed.     1                2                 3             4   
 
   6.  My pet makes me laugh and play.    1                2                 3             4 
 
   7.  Having a pet gives me something to love.   1                2                 3             4 
 
   8.  I get comfort from touching my pet.    1                2                 3             4 
 
   9.  I enjoy watching my pet.     1                2                 3             4 
 
  10.  My pet makes me feel loved.     1                2                 3             4 
 
  11.  My pet makes me feel trusted.                 1                2                 3             4 
 
 
 
You are now done with the survey.  THANK YOU VERY MUCH!
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